Finex logo
Finex Intelligence

Market Signal Briefing

Wire-ready dashboard awaiting your first source connection.

Last news saved at Mar 30, 13:54 27d ago Cron last ran Mar 30, 13:54 27d ago Awaiting first source
Switch language
91,488 Stories ingested Auto-fetched market intel nonstop.
0 Distinct tickers Add sources to start tracking symbols
Trending sources Waiting for fresh intel
Hot tickers Surfacing from current coverage
Details Saved Published Title Source Tickers
2025-12-15 18:31 4mo ago
2025-12-15 13:11 4mo ago
Luminar Technologies Files for Bankruptcy stocknewsapi
LAZR
The company plans to sell its Luminar Semiconductors subsidiary to Quantum Computing for $110 million.
2025-12-15 18:31 4mo ago
2025-12-15 13:11 4mo ago
Will Lamb Weston (LW) Beat Estimates Again in Its Next Earnings Report? stocknewsapi
LW
Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Lamb Weston (LW - Free Report) , which belongs to the Zacks Food - Miscellaneous industry.

This frozen foods supplier has an established record of topping earnings estimates, especially when looking at the previous two reports. The company boasts an average surprise for the past two quarters of 36.49%.

For the most recent quarter, Lamb Weston was expected to post earnings of $0.54 per share, but it reported $0.74 per share instead, representing a surprise of 37.04%. For the previous quarter, the consensus estimate was $0.64 per share, while it actually produced $0.87 per share, a surprise of 35.94%.

Price and EPS Surprise

With this earnings history in mind, recent estimates have been moving higher for Lamb Weston. In fact, the Zacks Earnings ESP (Expected Surprise Prediction) for the company is positive, which is a great sign of an earnings beat, especially when you combine this metric with its nice Zacks Rank.

Our research shows that stocks with the combination of a positive Earnings ESP and a Zacks Rank #3 (Hold) or better produce a positive surprise nearly 70% of the time. In other words, if you have 10 stocks with this combination, the number of stocks that beat the consensus estimate could be as high as seven.

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a version of the Zacks Consensus whose definition is related to change. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Lamb Weston has an Earnings ESP of +0.45% at the moment, suggesting that analysts have grown bullish on its near-term earnings potential. When you combine this positive Earnings ESP with the stock's Zacks Rank #3 (Hold), it shows that another beat is possibly around the corner. The company's next earnings report is expected to be released on December 19, 2025.

When the Earnings ESP comes up negative, investors should note that this will reduce the predictive power of the metric. But, a negative value is not indicative of a stock's earnings miss.

Many companies end up beating the consensus EPS estimate, but that may not be the sole basis for their stocks moving higher. On the other hand, some stocks may hold their ground even if they end up missing the consensus estimate.

Because of this, it's really important to check a company's Earnings ESP ahead of its quarterly release to increase the odds of success. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
2025-12-15 18:31 4mo ago
2025-12-15 13:11 4mo ago
Oracle: Let It Fall, Let It Fall, Let It Fall stocknewsapi
ORCL
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
2025-12-15 18:31 4mo ago
2025-12-15 13:13 4mo ago
US FTC, 21 states file amended complaint against Uber alleging deceptive billing practices stocknewsapi
UBER
The U.S. Federal Trade Commission said it and 21 states, along with the District of Columbia, have filed an amended complaint against ride-hailing app Uber alleging it engaged in deceptive billing and cancellation practices.
2025-12-15 18:31 4mo ago
2025-12-15 13:17 4mo ago
JetBlue flight averts mid-air collision with US Air Force jet stocknewsapi
JBLU
A JetBlue passenger jet bound for New York took evasive action on Friday to avoid a mid-air collision with a U.S. Air Force plane near Venezuela, a pilot said in an air traffic control recording.
2025-12-15 18:31 4mo ago
2025-12-15 13:19 4mo ago
Why ServiceNow's stock is sinking toward its worst day in 11 months stocknewsapi
NOW
The stock drop reflects concerns that ServiceNow could get more acquisitive in a bid to ignite growth.
2025-12-15 18:31 4mo ago
2025-12-15 13:20 4mo ago
Trade Tracker: Stephanie Link buys Union Pacific stocknewsapi
UNP
Stephanie Link, CIO at Hightower, joins CNBC's "Halftime Report" to detail her latest portfolio move
2025-12-15 18:31 4mo ago
2025-12-15 13:21 4mo ago
Why SCHD Is Still the King of Dividend ETFs stocknewsapi
SCHD
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

Investors love an ETF that offers a perfect balance between a good yield and some upside. The Schwab US Dividend Equity ETF (NYSEARCA:SCHD) was the perfect fit, and it became one of the most well-known stocks in the market. However, the upside portion of that equation has been missing at a time when the broader market is seeing an unceasing rally.

SCHD’s performance has been -0.25% in the past year, as of this writing. It only turns positive when you factor in the dividends. If you stretch the timescale back to the start of 2022, SCHD has again only appreciated by some 2% since then.

This is an unacceptable performance for many who’ve seen ETFs like the Vanguard High Dividend Yield Index Fund ETF (NYSEARCA:VYM) whiz by with a fat 11.08% return in the past year.

So, is it time to dump SCHD once and for all and move elsewhere? I disagree, and here’s why.

Why SCHD has underperformed in recent years
SCHD is the kind of ETF you want to hold over decades, and if there are stretches where it underperforms, that is to be expected. Let’s take a look at what caused SCHD to underperform recently.

First things first, though, I’ll begin by taking a look at the aforementioned VYM ETF. It’s performing very well and comes with a 2.41% dividend yield. That’s nowhere near SCHD’s 3.78%, but the capital appreciation is still enough for a dividend investor to contemplate ditching SCHD for VYM.

But do you know what the secret is?

VYM’s largest holding is Broadcom (NASDAQ:AVGO) with an 8.24% weighting. This is followed by JPMorgan (NYSE:JPM) at 4.17%. Financials and Technology stocks together constitute some 39% of VYM. As expected, it has done very well, but the downside risk is quite high.

SCHD’s sector breakdown shows Energy sector stocks at 19.69%, followed by Consumer Defensive stocks at 17.94%, and Health Care sector stocks at 17.46%. The top holding is Merck (NYSE:MRK) with a 4.61% weighting. This is a stronger composition that will allow SCHD to weather recessions better. Concurrently, this composition is making SCHD miss out on the tech rally. That’s mostly to blame for its underperformance.

Don’t ditch SCHD before taking this into account
It’s completely okay to trim some SCHD holdings if you want to chase more growth, but you may be taking on more risk, especially with certain ETFs. Covered-call ETFs are drawing lots of attention right now, as they are tracking popular tech indices that have done really well.

Some of them give you a double-digit yield and healthy upside through options.

Be that as it may, it pays to be skeptical. These ETFs have done and will do very well through a rally, but if a downturn hits, you’re going to be much more exposed to the downside risk than the upside. The famous JPMorgan Equity Premium Income ETF (NYSEARCA:JEPI) has been unable to claw back to 2025 highs after the selloff this spring, because the ETF’s composition limits upside while you take downside risk close to that of the original index.

Does that mean you should avoid JEPI entirely? Not at all. You can still buy it if you expect the tech rally to continue, but having SCHD in your portfolio can add the ballast you need if a downturn hits unexpectedly.

SCHD is still the King if you zoom out
If you look at SCHD’s capital appreciation chart, it looks woefully uninviting. Once you factor in the reinvested dividends, everything changes.

Here’s SCHD vs VYM. The long-term trendline still shows SCHD in the lead.

Here’s SCHD against JEPI since the latter’s inception.

I could go on…

Anyhow, you’ll quickly realize that ETFs beating SCHD are usually riskier and/or contain lower dividends, and they’ve only gotten ahead just recently. SCHD has historically been a great holding, and I expect it to continue outperforming if you plan to hold for decades instead of years. I wouldn’t fully ditch it.
2025-12-15 18:31 4mo ago
2025-12-15 13:21 4mo ago
Surging Earnings Estimates Signal Upside for Synopsys (SNPS) Stock stocknewsapi
SNPS
Synopsys (SNPS - Free Report) could be a solid addition to your portfolio given a notable revision in the company's earnings estimates. While the stock has been gaining lately, the trend might continue since its earnings outlook is still improving.

The rising trend in estimate revisions, which is a result of growing analyst optimism on the earnings prospects of this maker of software used to test and develop chips, should get reflected in its stock price. After all, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. Our stock rating tool -- the Zacks Rank -- has this insight at its core.

The five-grade Zacks Rank system, which ranges from a Zacks Rank #1 (Strong Buy) to a Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record of outperformance, with Zacks #1 Ranked stocks generating an average annual return of +25% since 2008.

For Synopsys, strong agreement among the covering analysts in revising earnings estimates upward has resulted in meaningful improvement in consensus estimates for the next quarter and full year.

The chart below shows the evolution of forward 12-month Zacks Consensus EPS estimate:

12 Month EPS

Current-Quarter Estimate RevisionsThe earnings estimate of $3.38 per share for the current quarter represents a change of +11.6% from the number reported a year ago.

Over the last 30 days, the Zacks Consensus Estimate for Synopsys has increased 16.53% because one estimate has moved higher compared to no negative revisions.

Current-Year Estimate RevisionsThe company is expected to earn $14.06 per share for the full year, which represents a change of +8.9% from the prior-year number.

There has been an encouraging trend in estimate revisions for the current year as well. Over the past month, one estimate has moved up for Synopsys versus one negative revision. This has pushed the consensus estimate 10.76% higher.

Favorable Zacks RankOur research shows that stocks with Zacks Rank #1 (Strong Buy) and 2 (Buy) significantly outperform the S&P 500.

Bottom LineSynopsys shares have added 16.2% over the past four weeks, suggesting that investors are betting on its impressive estimate revisions. So, you may consider adding it to your portfolio right away to benefit from its earnings growth prospects.
2025-12-15 18:31 4mo ago
2025-12-15 13:23 4mo ago
STUB Investor Alert: Hagens Berman Urges Investors to Act by Jan. 23 Over 143% Free Cash Flow Collapse and Alleged IPO Misrepresentations stocknewsapi
STUB
Partner Reed Kathrein Scrutinizing Allegedly Omitted Known Trends in Vendor Payments

, /PRNewswire/ -- National shareholder rights law firm Hagens Berman is issuing a reminder to investors in StubHub Holdings, Inc. (NYSE: STUB) ahead of the January 23, 2026, deadline of their opportunity to seek appointment as lead plaintiff in the pending securities class action lawsuit.

The litigation centers on allegations that StubHub's highly anticipated September 2025 Initial Public Offering (IPO) was launched using Offering Documents that contained material misstatements and omissions. Specifically, the lawsuit alleges the company failed to disclose crucial "known trends, events, or uncertainties" that were already adversely impacting its Free Cash Flow (FCF)—a key liquidity metric touted to prospective investors.

"This litigation focuses alleged violations of the Securities Act of 1933, which requires transparency for newly public companies. The complaint alleges that the Registration Statement was materially flawed because it failed to disclose the known trends regarding vendor payments, causing the stock to collapse shortly after the IPO," said Reed Kathrein, the Hagens Berman partner leading the firm's investigation in this matter.  "We urge investors in StubHub who purchased or otherwise acquired company shares pursuant to the IPO to contact the firm now."

Legal Analysis: Alleged Undisclosed Vendor Payment Trends and IPO Disclosure Failures

The complaint focuses on the alleged misrepresentations and omissions within the core offering documents, which led to a substantial loss of market capitalization:

Securities Act of 1933 Liability: The lawsuit alleges the Registration Statement and Prospectus were materially flawed, making Defendants liable to investors who acquired shares pursuant to the IPO.
Concealment of Known Trends: The Offering Documents allegedly failed to disclose adverse changes in the timing of payments to vendors—an alleged known trend that directly impacted liquidity.
143% Liquidity Collapse: The alleged omitted truth led to Q3 2025 results revealing Free Cash Flow was negative $4.6 million, marking a stunning 143% decline from the prior year. This revelation corrected the market's perception of the company's operational financial health.
Investor Damages: This disclosure caused the stock to fall well below the IPO price resulting in compensable damages for investors who acquired shares traceable to the IPO.

Next Steps: Contact Partner Reed Kathrein Today

Hagens Berman has a proven track record, securing significant recoveries for investors.

Mr. Kathrein and the firm's investor fraud team are actively advising investors who purchased STUB shares pursuant and/or traceable to the IPO and suffered significant losses due to the alleged undisclosed financial trends.

The Lead Plaintiff Deadline is January 23, 2026.

TO SUBMIT YOUR STUBHUB (STUB) INVESTMENT LOSSES NOW, PLEASE USE THE SECURE FORM BELOW:

Submit Your StubHub (STUB) IPO Losses
Contact: Reed Kathrein at 844-916-0895 or email [email protected]

If you'd like answers to frequently asked questions about the StubHub case and our investigation, read more »

Whistleblowers: Persons with non-public information regarding StubHub should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].

About Hagens Berman
Hagens Berman is a global plaintiffs' rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman's team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw. 

SOURCE Hagens Berman Sobol Shapiro LLP

Also from this source
2025-12-15 18:31 4mo ago
2025-12-15 13:23 4mo ago
Trade Tracker: Steve Weiss sells Vertiv stocknewsapi
VRT
Steve Weiss, Founder and Managing Partner of Short Hills Capital Partners joins CNBC's “Halftime Report” to explain why he's selling Vertiv.
2025-12-15 18:31 4mo ago
2025-12-15 13:24 4mo ago
Sage Potash Announces Further Financing Upsize to $14 Million stocknewsapi
SGPTF
Vancouver, British Columbia--(Newsfile Corp. - December 15, 2025) - Sage Potash Corp. (TSXV: SAGE) (OTCQB: SGPTF) ("Sage Potash" or the "Company") is pleased to announce that, further to its news releases dated December 8, 2025, December 10, 2025 and December 11, 2025, due to continued and significant investor interest, it has further upsized its non-brokered private placement (the "Offering") from $12 million to $14 million.

The Offering will now consist of up to 70,000,000 units of the Company (the "Units") at a price of $0.20 per Unit, with each Unit comprising one common share in the capital of the Company (a "Common Share") and one non-transferable Common Share purchase warrant (a "Warrant"). Each Warrant will be exercisable to purchase one Common Share at a price of $0.30 for a period of three (3) years from the date of closing of the Offering. All securities issued under the Offering will be subject to a hold period of four months and one day from the date of issuance under applicable securities laws.

Proceeds of the Offering will be used primarily to commence the work necessary to carry out key recommendations made by internationally recognized engineering firm, RESPEC LLC, in the Company's recently filed Preliminary Economic Assessment (see November 6, 2025 news release), including drilling of a stratigraphic hole, drill core analysis and testing and engineering review. The proceeds will also be used for working capital and for general and administrative expense purposes.

The Company may pay finders' fees in cash and/or securities of the Company in connection with the Offering.

Closing of the Offering is subject to TSX Venture Exchange acceptance.

About Sage Potash

Sage Potash Corp. (TSXV: SAGE) (OTCQB: SGPTF) is dedicated to the development of its flagship Sage Plain Potash Project, located in the Paradox Basin, Utah. With a large and high-grade resource base, the Company is advancing toward its goal of establishing a secure and sustainable domestic potash production platform in the United States. Sage Potash is committed to food security, environmental stewardship, and creating value for shareholders and stakeholders alike.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Note Regarding Forward-Looking Statements

This news release contains "forward-looking information" and "forward-looking statements" within the meaning of applicable securities legislation. The forward-looking statements herein are made as of the date of this news release only, and the Company does not assume any obligation to update or revise them to reflect new information, estimates or opinions, future events or results or otherwise, except as required by applicable law. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "expects", "is expected", "budgets", "scheduled", "estimates", "forecasts", "predicts", "projects", "intends", "targets", "aims", "anticipates" or "believes" or variations (including negative variations) of such words and phrases or may be identified by statements to the effect that certain actions "may", "could", "should", "would", "might" or "will" be taken, occur or be achieved. Forward-looking information in this news release includes, but is not limited to, statements regarding the Offering and with respect to future events or future performance of Sage Potash. Forward-looking statements and information are subject to various known and unknown risks and uncertainties, many of which are beyond the ability of the Company to control or predict, that may cause the Company's actual results, performance or achievements to be materially different from those expressed or implied thereby, and are developed based on assumptions about such risks, uncertainties and other factors set out herein, including, but not limited to, the risk factors set out under the heading "Risk Factors and Uncertainties" in the Company's Management's Discussion & Analysis available for review under the Company's profile at www.sedarplus.ca. Such forward-looking information represents management's best judgement based on information currently available. No forward-looking statement can be guaranteed and actual future results may vary materially. Accordingly, readers are advised not to place undue reliance on forward-looking statements or information.

Not for distribution to U.S. news wire services or dissemination in the United States

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/278080

Source: Sage Potash Corp.

Ready to Announce with Confidence?
Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us
2025-12-15 18:31 4mo ago
2025-12-15 13:24 4mo ago
Bright Minds Biosciences has standout year with epilepsy drug in Phase II trials stocknewsapi
DRUG
For three decades, central nervous system (CNS) drug development was a tough space for investors, scarred by failed bets on Alzheimer's disease, plateauing first-generation antidepressants, and setbacks in safety and efficacy.  

But advances in receptor-selective chemistry and so-called “biased agonism” – steering toward therapeutic pathways and away from areas that cause side effects – are reviving interest in the field.  

Successes such as esketamine for depression or cannabinoids for epilepsy have shown that carefully targeted mechanisms can deliver commercial as well as clinical breakthroughs.  

That shift is fuelling a new wave of investment in CNS-focused solutions, with several biotech companies absorbed by larger players in recent years.  

One of the companies that illustrates this shift is Bright Minds Biosciences Inc (CSE:DRUG), which is now in Stage II trials for its lead epilepsy drug. The company’s dramatic share performance in the past 12 months, involving appreciation of approximately 5,000%, is why investors come to the biotech space. Bright Minds has certainly delivered. 

The company was founded seven years ago by former investment banker and current Chief Executive Officer, Ian McDonald, Dr. Alan Kozikowski, a pharmaceutical entrepreneur and one of the most prolific researchers in psychedelic drug discovery, and Dr. Gideon Shapiro, a veteran of CNS drug discovery with senior roles at Sandoz-Novartis and Forum. 

Bright Minds is seeking to prove that finely tuned serotonin-targeting drugs can succeed where other compounds have fallen short.  

Its lead compound, BMB-101, is being tested with two forms of childhood epilepsy, with data expected around the end of this year. 

The scientific premise is straightforward but ambitious: BMB-101 selectively activates the serotonin 5-HT2C receptor, known as 2C, a target known to influence neuronal activity. 

Activating that receptor indirectly boosts levels of the neurotransmitter gamma-aminobutyric acid (GABA), which calms neuronal pathways to aid normal brain function and helps prevent the electrical discharges that result in epilepsy. 

Several other medicines also target 2C, but BMB-101 avoids closely related receptors linked to undesirable effects.  

Past drugs in this space, including the diet drug fenfluramine, were plagued by serious cardiac and psychedelic side effects because they also activated the 2B and 2A receptors.  

Bright Minds’ molecule is designed to bypass those problems and also to avoid the desensitization and tolerance build-up that has undermined many chronic CNS therapies. 

“Our compound is an advancement from that – a safer version that doesn’t have the 2A and 2B liabilities,” says McDonald. 

BMB-101, which has IP protection out to 2041, is in Phase II studies for two types of epilepsy. 

One is developmental epileptic encephalopathies, catastrophic epilepsies which begin in childhood and continue throughout life, with high mortality rates and patients who generally experience a range of problems stemming from the epilepsy. 

“We're also looking at a separate population with absence epilepsy, which isn’t very well treated at the moment,” says McDonald.  

“Only a couple of therapies have been approved for it, and there's a significant unmet need in that patient population.” 

He says these current trials are due to produce results around the end of the year. 

An upswing in M&A in recent years suggests that large pharmaceutical groups are willing to pay for validated serotonin 2C assets. 

Zogenix, which commercialised fenfluramine, was acquired by Belgium’s UCB for up to US$1.9 billion in 2021; GW Pharmaceuticals was bought by Jazz Pharmaceuticals for US$7.2 billion in the same year; in October 2024, Denmark’s Lundbeck paid US$2.6 billion for Longboard Pharmaceuticals. 

This latter deal was potentially the most relevant for Bright Minds, as Longboard’s compound operates with a similar serotonin 2C mechanism, and it had recently completed its Phase II study when the deal was done. 

McDonald believes his lead compound could be superior, with high selectivity and applications in treatment-resistant epilepsy.  

“In chronic dosing situations these other compounds often develop tolerance, but our molecule is designed to minimize or eliminate that.” 

Within the serotonin 2C receptor there are different signalling pathways.  

BMB-101 works exclusively via the pathway responsible for the therapeutic effect, known as the Gq-protein signalling pathway, and avoids the beta-arrestin pathway, which is responsible for tolerance development. 

In earlier tests, the molecule demonstrated efficacy in numerous models of generalized seizures. 

While McDonald says it is “potentially a best-in-class drug,” he acknowledges that a lot can go wrong in clinical trials. “The difference here is we know the mechanism works and we know our drug is hitting it.” 

The reason Longboard was bought even before it had started Phase III studies, and that Bright Minds shares skyrocketed around 1,500% in the same week as that deal, is that epilepsy trials have strong predictability.  

“If you succeed in Phase II, you’re likely to succeed in Phase III,” says McDonald. “Also, fenfluramine was proven to work, and Longboard’s compound was superior. It was lower risk than many other drugs at that stage. Our compound works on the same mechanism, but we have the biased agonism feature against tolerance development – and ours is more convenient too. Longboard’s compound must be given three times a day and refrigerated throughout. We don’t have those issues.” 

While some investors may be crossing their fingers for suitors to swoop after Phase II, the company has a cash runway through to 2027 to take the molecule to the edge of commercialization. 

There is also a wider portfolio of intellectual property in the pipeline in neurology and psychiatry, with multiple programs of interest, all built off the strong medicinal chemistry background of its co-founders, with compounds that accentuate the benefits of the mechanism while avoiding negative side effects.  

One indication in the same 2C space is a debilitating disease called Prader-Willi syndrome, which has around 10,000 patients in the U.S. and starts in childhood, with patients generally having a developmental disability and experiencing some neuropsychiatric symptoms. 

Others include BMB-201, a non-hallucinogenic psychoplastogen for treatment-resistant depression. 

Those additional programs may offer upside optionality, but the company’s value will be determined by whether BMB-101 delivers the pivotal data investors are betting on. 

If BMB-101’s data lives up to McDonald’s billing, the company could suddenly find itself on more than a few corporate shopping lists. 
2025-12-15 18:31 4mo ago
2025-12-15 13:24 4mo ago
HydroGraph Clean Power aims for wider graphene adoption with fresh approach to ultra-pure production stocknewsapi
HGCPF
Investors are constantly on the hunt for disruptive products that completely change an industry’s dynamics. Disrupting the approach to manufacturing a game-changing product thus seems like taking things to an even higher level. 

That is what HydroGraph Clean Power Inc (CSE:HG, OTCQB:HGCPF) has been working on since 2017, when the company was formed to pursue the production of graphene in a way that resulted in higher purity, was more cost-effective, and more environmentally friendly than conventional methods. 

Fast-forward to 2025 and HydroGraph has reached its objective, with a readily scalable process that yields high-quality graphene while adhering to the founding team’s tenets. 

Graphene is perhaps best described as a super-material. Many times stronger than steel, it is also a highly efficient conductor of electricity and heat, impermeable, and very flexible, among other qualities. The process of incorporating it into products can require specialized knowledge, but it still has found a home in a long list of items, with composites, electronics, and biomedical products among the categories tipped to lead future applications. 

HydroGraph’s core technology is its patented detonation synthesis process, which is quite a departure from methods that begin with graphite from the ground. Instead, HydroGraph detonates hydrocarbon gases using acetylene and oxygen to generate synthetic graphene by turning the gas into a powder. 

One aspect of the process that makes it unique, according to the company, is its simplicity. Conducting the detonation process with high-purity feedstock yields graphene with a purity level on the order of 99.8%. Consistency is another competitive advantage for HydroGraph, as the company has been able to produce a virtually identical product each time it has scaled up output. 

And changing the details on the input side can produce different graphene types to meet the particular needs of a given customer. 

Technologies like these need protection, and in this regard HydroGraph holds three patents at present, with another eight pending. 

“A number of companies have tried to go around our patents and everything has been rejected by the U.S. Patent Office, so we feel strongly about our position in the market,” says HydroGraph Clean Power Chief Executive Officer Kjirstin Breure. 

Breure, who joined the company as its Chief Operating Officer in 2020 before becoming CEO in 2024, holds an MSc in Materials Science and Engineering from Arizona State University and has spent over a decade involved with emerging technologies in the commercial sector, including machine learning, data analytics, and blockchain. 

Commercialization of HydroGraph’s graphene is already underway, with more than 60 entities in various stages of testing it for potential inclusion in a wide range of products and industries. 

One of those, Hawkeye Biomedical, is using HydroGraph’s graphene in its Lung Enzyme Activity Profile (LEAP) lung cancer biosensors. And in late September, HydroGraph announced a letter of intent with SEADAR Technologies, a developer of subsea sensing and surveillance solutions, to integrate HydroGraph’s graphene materials and coating technologies into current and future SEADAR undersea products. 

Breure notes that the average development cycle for its customers is about 18 months. First is lab-scale testing, which leads to industrial trials where a potential customer experiments with HydroGraph’s materials. Assuming everything goes well, contract negotiation is the next step. 

An important venue for interacting with potential clients in the graphene industry is the Graphene Engineering Innovation Centre (GEIC) at the University of Manchester. HydroGraph has its own laboratory at the GEIC, which has established itself as a hub for companies looking to integrate graphene into their products. With deep expertise on site and all the right equipment, the GEIC is the perfect location for graphene suppliers and users to explore real business relationships. 

Current production capacity is 10 tons per year and new production units, in the form of the company’s patented Hyperion detonation chamber, can be built and brought onstream in as little as two to three months. 

HydroGraph’s first commercial unit, a 13,000 square foot facility located in Manhattan, Kansas, started production in 2022. The company’s second production facility will be established in Texas, in part because that state is one of the best places to source the acetylene used in the detonation process. 

Scaling up on the revenue generation front could feed quickly to the bottom line, as HydroGraph estimates that an outlay of US$10 million to US$15 million on production can generate more than $100 million in sales. 

With the ability to quickly increase production capacity and a healthy pipeline of potential customers, it is reasonable to expect new developments coming to light before long. 

“We will be announcing the gas partner that we are working with for a large-scale production facility where we have negotiated pipeline access for acetylene, and we are looking forward to announcing a relationship with the U.S. military,” Breure says. 

Breure adds that HydroGraph is planning to provide an update on the status of its submission to the U.S. Environmental Protection Agency and that contract announcements emerging from the company’s commercial pipeline are likely. 

“We have between 10 and 15 clients that are really in that last stage that could convert into revenue within the next year,” Breure says, adding that the company has generated “small amounts” of revenue thus far but expects a more significant revenue stream to be “kicking in next year.” 
2025-12-15 18:31 4mo ago
2025-12-15 13:25 4mo ago
Final Trades: Leidos Holding, Citigroup and the IYG stocknewsapi
C LDOS
The Investment Committee give you their top stocks to watch for the second half.
2025-12-15 18:31 4mo ago
2025-12-15 13:26 4mo ago
KMX Shareholder Notice: CarMax (KMX) Securities Fraud Lawsuit Filed Over Alleged Concealed Demand Pull-Forward and Auto Finance Portfolio Risk - Hagens Berman stocknewsapi
KMX
Partner Reed Kathrein Urges KMX Investors to Contact Firm Before January 2, 2026 Lead Plaintiff Deadline

, /PRNewswire/ -- National investor rights law firm Hagens Berman reminds investors that the Lead Plaintiff Deadline in the securities class action lawsuit against CarMax, Inc. (NYSE: KMX) -- January 2, 2026 – is rapidly approaching.

The lawsuit alleges that CarMax and certain of its executives misled investors about the true stability and growth prospects of its core business, leading to two separate and massive stock crashes. Hagens Berman urges investors who suffered substantial losses—particularly those affected by the total 44% stock decline following the September earnings miss and the November CEO termination—to contact the firm now to discuss their rights.

Class Period: Investors who purchased CarMax (KMX) securities between June 20, 2025, and November 5, 2025.

Lead Plaintiff Deadline: January 2, 2026.

The Dual Focus of the CarMax (KMX) Securities Fraud Suit

The complaint highlights two central, undisclosed issues that allegedly led to the stock's inflation and ultimate collapse:

Alleged
Concealment

Alleged Misrepresentations

Alleged Adverse Impact on
Business

Unsustainable
Demand

CarMax touted robust Q1 2026 growth, failing to
disclose that it was a temporary "pull-forward
of customer demand" (customers buying early
to avoid announced tariffs).

Distortion of core retail demand
and that could not be sustained in
later quarters.

CarMax Auto
Finance (CAF)
Risk

Management assured investors they "feel good
about our reserve."

Massive and unexpected
increase in Loan Loss Provision
($142 million) due to high default
risk, crippling future earnings.

Underlying
Business
Weakness

Executives allegedly assured investors of
"earnings growth for years to come."

CEO termination and drastic
cut to forward guidance,
signaling fundamental, systemic
weakness in business operations.

The complaint alleges that the truth was disclosed in two stages: First, on September 25, 2025, CarMax announced dismal Q2 results, including a 24% net EPS fall and a surprising $142 million loan loss provision—a 40% sequential jump. The stock fell 20%. Second, on November 6, 2025, the unexpected termination of the CEO amid weak Q3 guidance prompted another severe stock decline.

"The January 2nd deadline is critical for CarMax investors seeking a leadership role in this case," said Reed Kathrein, the Hagens Berman partner leading the firm's investigation of the alleged claims. "This lawsuit alleges not one, but two, massive stock drops caused by the alleged concealment of operational truths: that sales were artificially driven by a tariff event, and that the risk in the lending portfolio was escalating out of control. We are actively investigating whether management falsely assured investors of growth while the foundation of the business was allegedly showing these deep cracks."

What You Can Do: If you purchased CarMax (KMX) securities during the Class Period and suffered significant losses, you are encouraged to contact Hagens Berman immediately.

TO SUBMIT YOUR CARMAX (KMX) STOCK LOSSES NOW, PLEASE USE THE SECURE FORM BELOW:

KMX Loss Submission
Contact: Reed Kathrein, 844-916-0895 or email: [email protected]
Video: www.youtube.com/watch?v=t7pZGIVuGGo&feature=youtu.be

If you'd like more information and answers to frequently asked questions about the CarMax case and our investigation, visit Hagans Berman's KMX case-specific page: www.hbsslaw.com/investor-fraud/kmx 

Whistleblowers: Persons with non-public information regarding CarMax should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].

About Hagens Berman
Hagens Berman is a global plaintiffs' rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman's team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw.

SOURCE Hagens Berman Sobol Shapiro LLP
2025-12-15 18:31 4mo ago
2025-12-15 13:26 4mo ago
Calls of the Day: Las Vegas Sands, Costco and Trane Technologies stocknewsapi
COST LVS TT
The Investment Committee debate the latest Calls of the Day.
2025-12-15 18:31 4mo ago
2025-12-15 13:27 4mo ago
INSP Shareholder Notice: $42.04 Stock Drop at Inspire Medical Systems (INSP) Triggers Securities Fraud Lawsuit Over Concealed Medicare Billing Software Failures & Inspire V Inventory Glut stocknewsapi
INSP
Partner Reed Kathrein Urges Investors to Contact Firm Before January 5, 2026 Lead Plaintiff Deadline

, /PRNewswire/ -- National investor rights law firm Hagens Berman alerts INSP investors to the pending securities class action lawsuit against Inspire Medical Systems, Inc. (NYSE: INSP). The firm is urging INSP investors who suffered substantial losses to contact attorneys before the January 5, 2026, Lead Plaintiff Deadline. The lawsuit, which is currently pending in the U.S. District Court for the District of Minnesota, alleges that Inspire Medical and its executives misled investors by concealing critical operational failures surrounding the launch of its next-generation device, the Inspire V for obstructive sleep apnea.

Class Period: Investors who purchased Inspire Medical (INSP) securities between August 6, 2024, and August 4, 2025.

Lead Plaintiff Deadline: January 5, 2026

Submit Your INSP Losses Now: If you suffered a substantial loss on your INSP investment, you are encouraged to contact Hagens Berman Partner Reed Kathrein to discuss your legal rights:

Visit: www.hbsslaw.com/investor-fraud/insp Email: [email protected] Call: 844-916-0895

The Heart of the Inspire Medical Systems (INSP) Fraud Allegations

The securities class action complaint details how Inspire Medical allegedly assured investors of its "operational readiness" for the Inspire V launch, claiming it was ready "to throw the switch" for full commercial rollout. These assurances, the lawsuit contends, concealed fundamental failures that made a successful launch impossible, leading to a catastrophic guidance cut and stock crash.

The undisclosed operational issues that allegedly rendered the Company's statements materially false and misleading include:

Alleged
Concealment

The Truth Allegedly Revealed on Aug. 4, 2025

Impact on Business/Stock

Medicare &
Billing Readiness

The necessary software updates for Medicare
claims processing did not take effect until July 1,
2025, meaning implanting centers could not bill
for procedures, stalling early adoption.

Delayed Inspire V rollout and
bottlenecked revenue generation.

Excess Inventory
(Channel Glut)

Customers and treatment centers held a significant
surplus of the older Inspire IV device, impacting
demand for the new Inspire V product and
requiring an inventory "burn down."

The allegedly flawed Inspire V
launch led Inspire to slash its
2025 EPS guidance by over
80%.

Training &
Onboarding

"Many centers" had not completed the essential
training, contracting, and onboarding required to
implant the new device.

$42.04 per share drop and 32.4%
decline in value.

Hagens Berman's Investigation of the Alleged Claims

"Our focus remains on the alleged concealment of two critical points: the Medicare claims software failure and the inventory glut of the prior Inspire IV device," said Reed Kathrein, the Hagens Berman partner leading the firm's investigation. "The suit alleges that Inspire's stock collapse was the result of management allegedly prioritizing a narrative of seamless transition over operational reality."

What You Can Do?: If you purchased Inspire Medical (INSP) securities during the Class Period, you may have legal options. If you wish to discuss your rights or have information that may assist our investigation, please contact Hagens Berman

Submit Your Inspire Medical (INSP) Stock Losses Now
Contact: Reed Kathrein at 844-916-0895 or email [email protected]

If you'd like more information and answers to frequently asked questions about the Inspire case and our investigation, visit Hagens Berman's INSP dedicated case page: www.hbsslaw.com/investor-fraud/insp »

Whistleblowers: Persons with non-public information regarding Inspire should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].

About Hagens Berman
Hagens Berman is a global plaintiffs' rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman's team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw.

SOURCE Hagens Berman Sobol Shapiro LLP
2025-12-15 18:31 4mo ago
2025-12-15 13:29 4mo ago
MindWalk Holdings Corp. (HYFT) Q2 2026 Earnings Call Transcript stocknewsapi
HYFT
MindWalk Holdings Corp. (HYFT) Q2 2026 Earnings Call December 15, 2025 10:30 AM EST

Company Participants

Jennifer Bath - CEO, President & Non-Independent Director
Richard Areglado - Chief Financial Officer

Conference Call Participants

Swayampakula Ramakanth - H.C. Wainwright & Co, LLC, Research Division
Gary Purpura - Liberty Capital Investment Corporation

Presentation

Operator

Good morning, ladies and gentlemen, and thank you for joining us today for MindWalk's Second Quarter Fiscal 2026 Earnings Call. We appreciate your time and interest in MindWalk, formerly ImmunoPrecise Antibodies.

Today's call will be led by our CEO, Dr. Jennifer Bath and our CFO, Scott Areglado. They will provide a review of our financial performance, strategic initiatives and key operational highlights for the second quarter. A copy of today's presentation, along with our final financial statements and MD&A is available on our website.

Before we begin, I'd like to remind everyone that today's discussion will include forward-looking statements. These statements are based on current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially. Factors that could results, include among others, global political and economic conditions, changes in the market dynamics, competitive developments and other business risks. Unless otherwise noted, all financial figures discussed today are in Canadian dollars. These statements are made as of today, and MindWalk undertakes no obligation to update them, except as required by law.

For a more detailed discussion of risks and uncertainties, please refer to our filings with the SEC and Canadian securities regulators, including our most recent Form 20-F and other periodic reports.

I would now like to turn the call over to MindWalk's President and CEO, Dr. Jennifer Bath.

Jennifer Bath
CEO, President & Non-Independent Director

Thank you, Regina. Good morning everyone. Before i discuss our quarter, marked by strong financial performance, I want to frame
2025-12-15 17:31 4mo ago
2025-12-15 12:09 4mo ago
Portnoy Law Firm Announces Class Action on Behalf of Fiserv, Inc. Investors stocknewsapi
FISV
LOS ANGELES, Dec. 15, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Fiserv, Inc., (“Fiserv” or the "Company") (NASDAQ: FISV) investors of a class action on behalf of investors that bought securities between July 23, 2025 and October 9, 2025, inclusive (the “Class Period”). Fiserv investors have until January 5, 2026 to file a lead plaintiff motion.

Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 844-767-8529 or email: [email protected], to discuss their legal rights, or join the case via https://portnoylaw.com/fiserv. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.

The Class Action alleges that, during the Class Period, Defendants made misleading statements and omissions regarding the Company’s initiatives and projects.   In July 2025, Fiserv revised its 2025 guidance. Fiserv told the market that its guidance changes were based on a review, termed a “re-underwrit[ing],” of the Company’s new initiatives and products. The Company told investors that although certain of those initiatives and projects were delayed, they were fundamentally sound. Unbeknownst to investors, Fiserv’s representations to the market in July 2025 were false and misleading. As Fiserv would later admit in October 2025, the Company’s 2025 guidance disclosed in July 2025 was based on “assumptions . . . which would have been objectively difficult to achieve even with the right investment and strong execution.” Defendants’ materially false and misleading statements during the Class Period resulted in members of the Class purchasing or otherwise acquiring the Company’s securities at artificially inflated prices, thus causing damages when the truth was revealed.

The Portnoy Law Firm represents investors in pursuing claims caused by corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.

Lesley F. Portnoy, Esq.
Admitted CA, NY and TX Bar
[email protected]
310-692-8883
www.portnoylaw.com

Attorney Advertising
2025-12-15 17:31 4mo ago
2025-12-15 12:09 4mo ago
BAXTER CLASS ACTION DEADLINE 12/15: Bragar Eagel & Squire, P.C. Reminds Baxter International Stockholders to Contact the Firm Regarding Their Rights stocknewsapi
BAX
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Baxter (BAX) To Contact Him Directly To Discuss Their Options

If you purchased Baxter common stock between February 23, 2022 and October 29, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Melissa Fortunato directly at (212) 355-4648.

Click here to participate in the action.

NEW YORK, Dec. 15, 2025 (GLOBE NEWSWIRE) --

What’s Happening:

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Baxter International, Inc. (“Baxter” or the “Company”) (NYSE:BAX) in the United States District Court for the Northern District of Illinois on behalf of all persons and entities who purchased or otherwise acquired Baxter common stock between February 23, 2022 and October 29, 2025, both dates inclusive (the “Class Period”).Investors have until December 15, 2025 to apply to the Court to be appointed as lead plaintiff in the lawsuit. Allegation Details:

The Complaint alleges that throughout the Class Period, Defendants misled investors by failing to disclose that: (1) the Novum LVP suffered systemic defects that caused widespread malfunctions, including underinfusion, overinfusion, and complete non-delivery of fluids, which exposed patients to risks of serious injury or death; (2) Baxter was notified of multiple device malfunctions, injuries, and deaths from these defects; (3) Baxter's attempts to address these defects through customer alerts were inadequate remedial measures, when design flaws persisted and continued to cause serious harm to patients; (4) as a result, there was a heightened risk that customers would be instructed to take existing Novum LVPs out of service and that Baxter would completely pause all new sales of these pumps; and (5) based on the foregoing, Baxter's statements about the safety, efficacy, product rollout, customer feedback and sales prospects of the Novum LVPs were materially false and misleading. Next Steps:

If you purchased or otherwise acquired Baxter shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at [email protected], telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you. About Bragar Eagel & Squire, P.C.:

Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, California, and South Carolina. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.

Follow us for updates on LinkedIn, X, and Facebook, and keep up with other news by following Brandon Walker, Esq. on LinkedIn and X.

Contact Information:

Bragar Eagel & Squire, P.C.
Brandon Walker, Esq.
Melissa Fortunato, Esq.
(212) 355-4648
[email protected]
www.bespc.com
2025-12-15 17:31 4mo ago
2025-12-15 12:09 4mo ago
Fresenius SE & Co. KGaA (FSNUY) Analyst/Investor Day Transcript stocknewsapi
FSNUY
Fresenius SE & Co. KGaA (FSNUY) Analyst/Investor Day December 15, 2025 7:00 AM EST

Company Participants

Nick Stone - Senior VP of Investor Relations & Head of Investor Relations - Fresenius Management SE
Michael Sen - CEO, President & Chairman of Management Board of Fresenius Management SE
Pierluigi Antonelli - Member of Management Board of Fresenius Management SE & CEO of Fresenius Kabi
Sang-Jin Pak
Michael Hammer
Fabrice Romanet
Yannick Sorlet
Jurgen Van Broeck
Molly Benson

Conference Call Participants

Veronika Dubajova - Citigroup Inc., Research Division
Oliver Metzger - ODDO BHF Corporate & Markets, Research Division
David Adlington - JPMorgan Chase & Co, Research Division

Presentation

Nick Stone
Senior VP of Investor Relations & Head of Investor Relations - Fresenius Management SE

Hello, everyone. Welcome to the Inaugural Conference Call and Webcast as part of our new Meet the Management series. Today, we're kicking off with a deep dive into Biopharma. The presentation was e-mailed to our distribution list earlier today and is available on fresenius.com.

On Slide 2 of the presentation, you'll find the usual safe harbor statement. Unless stated otherwise, we'll comment using constant exchange rates or CER. In preparation for this call, we asked our investor and analyst research panel about the priority expectations, forgive me.

In short, you told us that you wanted more details on pipeline insights and competitive position, including time lines, scale of pipeline opportunity and differentiation relative to peers. You also asked about the growth drivers and long-term value creation, including greater transparency, revenue and margin impact with a clear growth road map, which we've addressed in the presentation and supplementary materials.

Today, I'm delighted to be joined by Michael Sen, Pierluigi, Sang-Jin Pak, and the broader Biopharma team. We will now take you through our ambitions and the agenda on Slide 3 in more detail.

Today's call will last approximately
2025-12-15 17:31 4mo ago
2025-12-15 12:10 4mo ago
Roomba Robot Vacuums Face a Shakeup as iRobot Files for Bankruptcy stocknewsapi
IRBT
Why You Can Trust CNET

Our expert, award-winning staff selects the products we cover and rigorously researches and tests our top picks. If you buy through our links, we may get a commission. Reviews ethics statement

iRobot says it will continue to offer its robots and smart home devices​ to consumers.

Connor Jewiss

Connor is a technology writer and editor, with a byline on multiple platforms. He has been writing for around nine years now across the web and in print too. Connor has attended the biggest tech expos, including CES, MWC, and IFA -- with contributions as a judge on panels at them. He's also been interviewed as a technology expert on TV and radio by national news outlets including France24. Connor has experience with most major platforms, though does hold a place in his heart for macOS, iOS/iPadOS, electric vehicles, and smartphone tech. Just like everyone else around here, he's a fan of gadgets of all sorts. Aside from writing, Connor is involved in the startup and venture capital scene, which puts him at the front of new and exciting tech -- he is always on the lookout for innovative products.

3 min read

Two decades after it ignited a market for robot vacuums in homes, iRobot has filed for Chapter 11 bankruptcy protection. The company, best known for its Roomba robot vacuums, entered the filing late Sunday night after months of warning signs and financial pressure.

Under the proposed restructuring, iRobot will be acquired by its primary manufacturing partner, China-based Shenzhen Picea Robotics.

The company said it will continue to offer robots and smart home devices to consumers.

Massachusetts-based iRobot, which launched the first Roomba in 2002, was once synonymous with the category it helped invent. But years of mounting robot vacuum competition, particularly from Chinese brands like Ecovacs and Roborock, have eroded its market share.

An attempted lifeline came in the form of an Amazon acquisition in 2022, which promised to bolster iRobot's position in the smart home space. However, that deal was ultimately scuttled by regulators on both sides of the Atlantic, leaving iRobot to fend for itself amid fierce competition.

In response, iRobot revamped its product line and worked with Picea to bring newer models to market, while also slashing prices to stay competitive. Despite those efforts, the company continued to lose ground. US tariffs didn't help.

Don't miss any of our unbiased tech content and lab-based reviews. Add CNET as a preferred Google source.

What the iRobot bankruptcy means for youThe acquisition by Picea, a contract manufacturer that already builds many of iRobot's products, is intended to allow operations to continue without interruption.

"Today's announcement marks a pivotal milestone in securing iRobot's long-term future," Gary Cohen, iRobot's chief executive officer, said in a statement Sunday. "The transaction will strengthen our financial position and will help deliver continuity for our consumers, customers, and partners." 

But while iRobot products remain on sale through major retailers including Amazon and Best Buy, whether you should still buy one, given the bankruptcy filing, is a complicated question.

"This will rightly have prospective buyers questioning whether to add one to their cleaning arsenal despite the company's promise to continue operating without disruption," CNET shopping expert Adam Oram said. "I wouldn't advise that shoppers rule out a Roomba on this news alone, with many discounted Roomba deals still offering great value even if the longevity of the product remains unknown."

Oram notes that iRobot's products are highly rated among users.  

But smart home history isn't exactly full of happy endings. Support can disappear quickly when companies change hands, and even well-intentioned promises can get lost in the shuffle of restructuring.

So yes, you can still buy a Roomba, and in the short term, it'll likely work just fine. But if you're shopping for a robot vacuum with years of app updates and new features in mind, you might want to look at Roomba alternatives from brands with a clearer future. Oram suggested Roborock, Ecovacs and Eufy, in particular.

iRobot, founded in 1990, says it plans to be in the game for the long haul.

"By combining iRobot's innovation, consumer-driven design, and R&D with Picea's history of innovation, manufacturing, and technical expertise, we believe iRobot will be well equipped to shape the next era of smart home robotics," Cohen said in the company's statement.  

Smart Home
2025-12-15 17:31 4mo ago
2025-12-15 12:10 4mo ago
Why Alphabet ETFs Could Get A Lift From SpaceX's $800 Billion Valuation Jump stocknewsapi
GOOG GOOGL
Alphabet Inc (NASDAQ:GOOGL)(NASDAQ:GOOG) could be heading for another earnings tailwind — and investors in ETFs may feel this before they realize why.

• Alphabet is in focus. Check its prices, live.

SpaceX, a closely held rocket and satellite technology firm established by Elon Musk, is in the process of completing a tender offer, which takes the total company value to approximately $800 billion, based on a Bloomberg report.

As part of this offering, insider shares are being valued at $421 each, thereby leading to a dramatic increase in the existing investment in the firm by Alphabet, which had a lower secondary stock value.

Though SpaceX is not available to public investors, a revaluation in this company can have a direct transfer into Alphabet-dominated ETFs, hence bringing back a common phenomenon where private markets have a silent impact on public market performance.

ETFs With Exposure To “The Hidden” SpaceX UpsideAlphabet does not break out individual private investments in its filings, but private valuations of SpaceX have appeared in its earnings statements before, especially in ETFs with heavy investments in Alphabet.

Nasdaq 100 index-tracking funds, such as the Invesco QQQ Trust (NASDAQ:QQQ), are major beneficiaries since Alphabet is one of the top components. A new accounting gain related to SpaceX may go a long way in ensuring Alphabet's bottom line is stronger without necessarily moving much in the advertising and cloud segments.

Communication Services ETFs have exposure as well. The Communication Services Select Sector SPDR Fund (NYSE:XLC) holds Alphabet among its top stocks, with around 20% exposure to both Class A and Class C shares. Also, a broader index such as the Vanguard Communication Services ETF (NYSE:VOX) will benefit from any profit surprise with respect to non-operating gains. VOX holds almost 15% in Alphabet across both types of shares.

On the other hand, equal-weight investment in S&P 500 or communication services sector ETFs will be less affected, which illustrates how concentrated exposure in mega-cap stocks can have a magnified impact on accounting-driven increases in earnings.

Also Read: SpaceX Worth $1.5 Trillion In 2026 IPO? Here’s How You Can Invest Ahead Of Public Offering

Why Alphabet’s Earnings Suddenly MatterAlphabet has been a SpaceX investor since at least 2015, when it participated in a $1 billion funding round with Fidelity Investments, with both investors acquiring a collective interest of approximately 10%, according to Bloomberg.

Back in early this year, Alphabet reported an $8 billion gain on what is widely believed to be SpaceX, based on a tender offer in late last year when it was valued at $350 billion. As a result, Alphabet reported a net income in the March quarter above market expectations despite a mixed performance in its main businesses.

Alphabet categorizes such gains into “unrealized gains on non-marketable equity securities,” which are reflections of private valuations being able to affect earnings without any stock being sold.

What Investors Will Be WatchingAs a continuation of this trend in the latest tender with a valuation over double last year's level, market players are expecting Alphabet's next earnings report to show another accounting increase, with resulting ETF flows.

During the last week of April this year, after Alphabet revealed the “unrealized” gains, there was a spike in inflows into XLC worth more than $102 million, according to data compiled by VettaFi.

For ETF investors, the episode is a reminder that exposure to mega-cap tech isn't just about AI, advertising or cloud growth. Sometimes, the real surprise comes from a private rocket company quietly lifting reported profits.

In this case, owning Alphabet through an ETF may turn out to be the closest thing to owning SpaceX.

Read Next:

Scott Galloway Calls SpaceX Incredible Company With ‘Bigger Moat’ Than OpenAI, But Refuses To Invest In It
Photo: Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
2025-12-15 17:31 4mo ago
2025-12-15 12:11 4mo ago
Neotech Metals Announces Distinct Apatite-Dominant Rare Earth Mineralization at Hecla-Kilmer stocknewsapi
NTMFF
Vancouver, British Columbia--(Newsfile Corp. - December 15, 2025) - Neotech Metals Corp. (CSE: NTMC) (OTCQB: NTMFF) (FSE: V690) ("Neotech" or "the Company") is pleased to report the results of a comprehensive and independent mineralogical study completed by SGS Lakefield ("SGS") on the Company's 100% owned Hecla-Kilmer ("H/K") Rare Earth & Critical Minerals Project in northern Ontario. These results confirm that up to 98% of total rare earth elements occur in apatite, and it is this distinctive apatite mineralogy, with exceptional leachability at low temperatures, that sets H/K apart.

Key Findings from SGS Lakefield Metalogical Study include:

Apatites contain uniquely high *TREO content (7.4% TREO), with the master composite accounting for approximately 82% of the *TREO distribution.Seven out of eight samples contain 85% or more of total rare earth elements (*TREEs) hosted in apatite,Apatite hosts up to 98% of *TREEs across the dataset,Apatite occurs as a major rock-forming mineral (28% to 56% abundance) within the sampled interval,Discrete rare earth minerals are present only in trace quantities, including synchysite (0.36%), monazite (0.05%), and bastnäsite (0.01%) in the Master Composite.This study establishes H/K as a fundamentally distinct rare earth system. Apatite occurs extensively across the sampled intervals and serves as the primary carrier of rare earth elements—an uncommon mineralization style globally. SGS further reports that monazite, synchysite, bastnäsite, allanite, and other rare earth minerals (REM) together account for less than 1% of the mineral assemblage, confirming that discrete rare earth minerals are only present at trace levels and that apatite overwhelmingly hosts the rare earth content.

Targeting Apatites

Extensive mineralogical work completed by SGS Canada confirms that rare earths at Hecla-Kilmer are overwhelmingly hosted within apatite, supported by a multi-method analytical program that included TIMA-X (Tescan Integrated Mineral Analyzer), EPMA (Electron Probe Micro Analysis), X-ray diffraction (XRD) and LA-ICP-MS (Laser Ablation by Inductively Couple Mass Spectrometry).

Eight representative variability samples, collected across the 361-metre interval in drill hole HK22-13 (which averaged 1% *TREO from bedrock surface), were examined to quantify both mineral abundance and mineral-specific rare earth deportment.

This mineralogical distribution establishes Hecla-Kilmer as a distinctly apatite-hosted rare earth system, fundamentally different from conventional monazite- or bastnäsite-dominant deposits. The independent SGS report confirms that the rare earth content resides largely within the apatite crystal lattice, rather than in separate refractory mineral grains nor inclusions within the individual apatite crystals.

This host-mineral relationship directly supports the exceptional low-temperature, low-acid leachability demonstrated in Neotech's metallurgical testwork announced on April 1, 2025. High liberation of apatite (80–92% across all samples) at moderate grind sizes further reinforces its suitability as the primary metallurgical target for rare earth extraction.

The combined mineralogical and metallurgical datasets now provide a consistent, independent confirmation of the unique processing advantages inherent to the Hecla-Kilmer system.

Figure 1 – Table showing respective samples and Lanthanum dispersions throughout various holes, with 6 samples exhibiting >90% in the apatite crystal structures.

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/9768/278003_ed8e49ab74221a7d_001full.jpg

“Hecla-Kilmer continues to distinguish itself from every comparable rare earth system we have studied,” stated CEO, Reagan Glazier, in comment. “The confirmation that rare earths are overwhelmingly hosted within apatite, gives this project a unique foundation among known rare earth deposits. Our metallurgical work has already shown the advantages associated with this style of mineralization, and together these results position Hecla-Kilmer as a potential significant source of critical minerals within a modern supply chain. We are very encouraged by the continued progress at the project as we advance and derisk a rare earth system that aligns with the goals of secure and sustainable value-added supply chains needed for the green transition.”

2025 Hecla-Kilmer Drill Campaign

During 2025 the Company successfully completed approximately 8,000 meters of drilling at H/K, as well as re-logging and re-assaying approximately 1,900 meters of core drilled by the previous owner, VR Resources Ltd. between 2020-2023 for the full rare earth suite and is to be included in the Maiden Resource Estimate ("MRE"), expected to come in 2026.

Qualified Person

Technical Information for this news release has been prepared in accordance with the Canadian regulatory requirements set out in National Instrument 43-101. Jared Galenzoski VP Exploration, P.Geo., and Qualified Person, has reviewed and approved all of the data and statements made for this news release.

About the Neotech Metals

Neotech Metals Corp. (CSE: NTMC) (OTCQB: NTMFF) (FSE: V690) is a mineral exploration company dedicated to discovering and developing valuable mineral resources within promising jurisdictions around the world. With a strong commitment to environmental stewardship and sustainable practices, Neotech is positioned to make a positive impact while maximizing the potential of its exploration properties.

The Company holds 100% ownership in three high-quality strategic Rare-Earth Element and Rare Metals projects, including the Hecla-Kilmer, located 20 km from the Otter Rapids 180MW hydroelectric power generation station and active Ontario Northway railway, along with its TREO and Foothills projects located in British Columbia.

For additional information on NTMC, please visit the Company's website at www.neotechmetals.com.

ON BEHALF OF THE BOARD
Reagan Glazier, Chief Executive Officer and Director
Neotech Metals Corp.

*TREO (Total Rare-Earth Oxides) has been used to express the results in the press release. TREO is calculated by converting the elemental ppm to Rare-Earth Oxides using a conversion factor and is the summation of CeO2 + La2O3 + Pr6O11 + Nd2O3 + Sm2O3 + Eu2O3 + Gd2O3 + Tb4O7 + Dy2O3 + Ho2O3 + Er2O3 + Tm2O3 + Yb2O3 + Lu2O3 + Y2O3.

*TREE (Total Rare-Earth Elements) has been used to express the results in the press release. TREE is calculated by summing the elemental ppm of Rare-Earth Elements Ce + La + Pr + Nd + Sm + Eu + Gd + Tb + Dy + Ho + Er + Tm + Yb + Lu + Y.

**PMREO (Permanent Magnet Rare-Earth Oxides) has been used to express the results in the press release. TREO is calculated by converting the elemental ppm to Rare-Earth Oxides using a conversion factor and is the summation of Pr6O11 + Nd2O3 + Tb4O7 + Dy2O3.

Forward-Looking Statements

Certain information contained herein constitutes "forward-looking information" under Canadian securities legislation. Generally, forward-looking information can be identified by the use of forward-looking terminology such as "will", "will be" or variations of such words and phrases or statements that certain actions, events or results "will" occur. Forward-looking statements are based on the opinions and estimates of management as of the date such statements are made and they are from those expressed or implied by such forward-looking statements or forward-looking information subject to known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different, including receipt of all necessary regulatory approvals. Although management of the Company have attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. The Company will not update any forward-looking statements or forward-looking information that are incorporated by reference herein, except as required by applicable securities laws.

Neither the CSE nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/278003

Source: Neotech Metals Corp.

Ready to Announce with Confidence?
Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us
2025-12-15 17:31 4mo ago
2025-12-15 12:11 4mo ago
Is Rapid Apparel Growth the Next Catalyst for On Holding? stocknewsapi
ONON
Key Takeaways ONON's apparel net sales jumped 86.9% to CHF 50.1M in Q3, up 100.2% in constant currency terms.Apparel growth was broad-based across DTC, wholesale and all major geographic regions.Apparel sales hit 1M units in Q3, raising category share to 6.3% from 4.2% a year earlier.
On Holding AG’s (ONON - Free Report) apparel business experienced significant growth in the third quarter of fiscal 2025, with net sales soaring 86.9% year over year to CHF 50.1 million. On a constant currency basis, the growth was even more impressive at 100.2%. This shows that the increase in net sales was driven by demand rather than foreign exchange effects. The strong performance indicates that the company's multi-dimensional growth strategy is succeeding beyond its core footwear segment.

Management emphasized that the apparel share grew across both direct-to-consumer and wholesale channels and across all major geographic regions, demonstrating that the category is resonating globally. Apparel is quickly becoming a vital part of the business, with sales penetration rising to 6.3% in the third quarter from 4.2% a year earlier.

Performance Running and Performance Training verticals were cited as the main contributors to the quarter’s apparel growth, supported by growing consumer adoption and increased purchase frequency. Management describes apparel as a “company within the company,” highlighting its strategic relevance and role in attracting first-time buyers, who often expand their purchases into other categories.

This success confirms that the brand is strengthening its connection with customers through this burgeoning apparel segment. Management noted that for the first time in the third quarter, they sold more than one million apparel items. The expansion of the apparel business is crucial to achieving the vision of becoming a true toe-to-head partner for consumers. The ability to attract fans into this product category, including those new to performance-inspired apparel, affirms the brand's broadening appeal.

What the Latest Metrics Say About ON HoldingON Holding, which competes with Deckers Outdoor Corporation (DECK - Free Report) and Wolverine World Wide, Inc. (WWW - Free Report) , has seen its shares rally 17.8% in the past month compared with the industry’s rise of 19.3%. Shares of Deckers and Wolverine have jumped 25.3% and 23%, respectively, in the aforementioned period.
 

Image Source: Zacks Investment Research

From a valuation standpoint, ON Holding trades at a forward price-to-earnings (P/E) ratio of 28.93, higher than the industry’s 18.32. ONON carries a Value Score of F. ON Holding is trading at a premium to Deckers (with a forward 12-month P/E ratio of 15.13) and Dollar General (19.60). 

Image Source: Zacks Investment Research

The Zacks Consensus Estimate for ON Holding’s current financial-year sales implies year-over-year growth of 41.2%, while the same for earnings per share suggests a decline of 12.7%.
 

Image Source: Zacks Investment Research

ON Holding currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
2025-12-15 17:31 4mo ago
2025-12-15 12:15 4mo ago
Berry Stockholders Approve Combination with CRC stocknewsapi
BRY
December 15, 2025 12:15 ET

 | Source:

Berry Corporation (Bry)

DALLAS, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Berry Corporation (bry) (NASDAQ: BRY) (“Berry”) today announced that, at its Special Meeting of Stockholders held earlier today, Berry stockholders voted to approve its combination with California Resources Corporation (“CRC”) (NYSE: CRC). As previously announced, under the terms of the merger agreement, Berry stockholders will receive a fixed exchange ratio of 0.0718 shares of CRC common stock for each share of Berry common stock.

According to preliminary results, Berry stockholders approved the transaction with approximately 73% of the total shares outstanding and approximately 98% of the shares voted in support of the combination. The final voting results of Berry’s Special Meeting will be reported in a Form 8-K to be filed with the U.S. Securities and Exchange Commission (the “SEC”).

The closing of the transaction is expected to occur on December 18.

About Berry Corporation (BRY)

Berry is a publicly traded western United States independent upstream energy company with a focus on onshore, low geologic risk, long-lived oil and gas reserves. We operate in two business segments: (i) exploration and production (“E&P”) and (ii) well servicing and abandonment services. Our E&P assets are located in California and Utah, are characterized by high oil content and are predominantly located in rural areas with low population. Our California assets are in the San Joaquin Basin (100% oil), and our Utah assets are in the Uinta Basin (70% oil). We provide our well servicing and abandonment services to third party operators in California and our California E&P operations through C&J Well Services (CJWS).

FORWARD-LOOKING STATEMENTS

Statements we make regarding the closing of the proposed transaction constitute forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and other securities laws. Such forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in such statements. These risks and uncertainties include, but are not limited to, the risk that any of the closing conditions to the proposed transaction may not be satisfied in a timely manner. Additional information concerning these and other important risks and uncertainties are described in the “Risk Factors” section of the definitive proxy statement/prospectus that was filed by Berry with the SEC on November 4, 2025, and other documents filed by Berry from time to time with the SEC. We caution you not to place undue reliance on forward-looking statements contained in this press release, which speak only as of the date hereof. Berry is under no obligation, and expressly disclaims any obligation to update, alter or otherwise revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact        

Contact: Berry Corporation (bry)
Christopher Denison: Director – Investor Relations & Sustainability
[email protected]
(661) 616-3811
2025-12-15 17:31 4mo ago
2025-12-15 12:15 4mo ago
Athena Gold Closes Second Tranche of Non-brokered Private Placement and Increases Offering Due to Strong Demand stocknewsapi
AHNRF
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT AUTHORIZED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

WHITE ROCK, BRITISH COLUMBIA / ACCESS Newswire / December 15, 2025 / Athena Gold Corporation (CSE:ATHA)(OTCQB:AHNRF) ("Athena Gold" or the "Company") is pleased to announce that, further to its news releases of November 17, November 24 and December 9, 2025, the Company has closed the second tranche of its private placement financing (the "Offering") and has received proceeds of CDN $270,499.98 through the issuance of 150,000 flow-through units (the "FT Units") at CDN $0.07 per FT Unit and 4,333,333 non-flow-through units (the "NFT Units") at CDN $0.06 per NFT Unit. An aggregate of CDN $2,727,526.03 was raised in the first tranche of the Offering.

Due to increased demand, the Company sought and received approval from the Canadian Securities Exchange to an increase in the Offering, to include an increase in the number of FT Units forming part of the Offering, from the original CDN $1,500,000 (21,428,571 FT Units) up to CDN $2,200,000, for an additional 10,000,000 FT Units. The total Offering now consists of up to CDN $4,200,000 consisting of (i) CDN $2,200,000 through the issuance of up to 31,428,571 flow-through units (the "FT Units") at a price of CDN $0.07 per FT Unit, (ii) CDN $1,100,000 through the issuance of up to 15,714,296 flow-through common shares (the "CMETC FT Shares") at a price of CDN $0.07 per CMETC FT Share, and (iii) CDN $900,000 through the issuance of up to 15,000,000 non-flow-through units ("NFT Units") at a price of $CDN $0.06 per NFT Unit. All other terms and conditions remain constant.

Closing of the third tranche is expected to occur by the end of this week.

Each FT Unit is comprised of one flow-through common share (a "FT Share") and one-half of a non-flow-through share purchase warrant (a "FT Warrant"), with each whole FT Warrant exercisable for one non-flow-through common share at an exercise price of CDN $0.09 for a term of 24 months after closing subject to an acceleration clause. If, at any time after the date that is 4 months and one day after the date of issuance of the FT Warrants, the average volume weighted trading price of Athena's common shares on the Canadian Securities Exchange is at or above CDN $0.14 per share for a period of 10 consecutive trading days (the "Triggering Event"), Athena may at any time, after the Triggering Event, accelerate the expiry date of the FT Warrants by giving ten calendar days' notice to the holders of the FT Warrants, by way of news release, and in such case the FT Warrants will expire on the first day that is 30 calendar days after the date on which such notice is given by Athena announcing the Triggering Event.

Each NFT Unit is comprised of one non-flow-through common share and one non-flow-through share purchase warrant (a "NFT Warrant"), with each NFT Warrant exercisable for one non-flow-through common share at an exercise price of CDN $0.09 for a term of 24 months after closing subject to an acceleration clause. If, at any time after the date that is 4 months and one day after the date of issuance of the NFT Warrants, the average volume weighted trading price of Athena's common shares on the Canadian Securities Exchange is at or above CDN $0.14 per share for a period of 10 consecutive trading days (the "Triggering Event"), Athena may at any time, after the Triggering Event, accelerate the expiry date of the NFT Warrants by giving ten calendar days' notice to the holders of the NFT Warrants, by way of news release, and in such case the NFT Warrants will expire on the first day that is 30 calendar days after the date on which such notice is given by Athena announcing the Triggering Event.

Each of the FT and CMETC FT Shares will qualify as "flow-through shares" of the Company as defined in section 66(15) of the Income Tax Act (Canada). The CMETC FT Shares will also qualify for the Canadian government's Critical Mineral Exploration Tax Credit. Proceeds will be spent on the Company's Laird Lake and Oneman Lake Projects located in Ontario, that will qualify as "Canadian Exploration Expenses" and "flow-through critical mineral mining expenditures" as those terms are defined in the Income Tax Act (Canada), which will be renounced to the purchasers with an effective date no later than December 31, 2025.

The proceeds from the sale of the NFT Units will be used for additional exploration work on the Company's properties and for general and administrative expenses and working capital purposes.

No finder's fees were paid in connection with the closing of the second tranche, nor did any insiders participate in the second tranche.

All securities issued in connection with the Offering are subject to a four-month and one-day hold period.

None of the foregoing securities have been or will be registered under the United States Securities Act of 1933, as amended (the "1933 Act") or any applicable state securities laws and may not be offered or sold in the United States or to, or for the account or benefit of, U.S. persons (as defined in Regulation S under the 1933 Act) or persons in the United States absent registration or an applicable exemption from such registration requirements. This press release does not constitute an offer to sell or the solicitation of an offer to buy nor will there be any sale of the foregoing securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.

About Athena Gold Corporation

Athena Gold is engaged in the business of mineral exploration and the acquisition of mineral property assets. Its objective is to locate and develop economic precious and base metal properties of merit and to conduct additional exploration drilling and studies on its projects across North America. Athena Gold's Laird Lake project is situated in the Red Lake Gold District of Ontario, covering over 4,000 hectares along more than 10 km of the Balmer-Confederation Assemblage contact, where recent surface sampling results returned up to 373 g/t Au. This underexplored area is road-accessible, located about 10 km west of West Red Lake Gold's Madsen mine and 34 km northwest of Kinross Gold's Great Bear project. Meanwhile, its Excelsior Springs Au-Ag project is located in the prolific Walker Lane Trend in Nevada, where it us currently under option by Firetail Resources Limited. Excelsior Springs spans over 1,500 hectares and covers at least three historic mines.

For further information about Athena Gold Corporation and our Excelsior Springs Gold project, please visit www.athenagoldcorp.com.

On Behalf of the Board of Directors

Koby Kushner
President and Chief Executive Officer, Athena Gold Corporation

For further information, please contact:

Athena Gold Corporation
Koby Kushner, President and Chief Executive Officer
Phone: 416-846-6164
Email: [email protected]

CHF Capital Markets
Cathy Hume, CEO
Phone: 416-868-1079 x 251
Email: [email protected]

Forward-Looking Statements

This press release contains forward-looking statements and forward-looking information (collectively, "forward-looking statements") within the meaning of applicable Canadian and US. securities laws. All statements, other than statements of historical fact, included herein, including, without limitation, statements regarding future exploration plans, future results from exploration, and the anticipated business plans and timing of future activities of the Company, are forward-looking statements. Although the Company believes that such statements are reasonable, it can give no assurance that such expectations will prove to be correct. Forward-looking statements are typically identified by words such as: "believes", "will", "expects", "anticipates", "intends", "estimates", ''plans", "may", "should", ''potential", "scheduled", or variations of such words and phrases and similar expressions, which, by their nature, refer to future events or results that may, could, would, might or will occur or be taken or achieved. In making the forward-looking statements in this press release, the Company has applied several material assumptions, including without limitation, that there will be investor interest in future financings, market fundamentals will result in sustained precious metals demand and prices, the receipt of any necessary permits, licenses and regulatory approvals in connection with the future exploration and development of the Company's projects in a timely manner.

The Company cautions investors that any forward-looking statements by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward-looking statements.

Readers are cautioned not to place undue reliance on forward-looking statements. The Company undertakes no obligation to update any of the forward-looking statements in this press release or incorporated by reference herein, except as otherwise stated.

Neither the Canadian Securities Exchange nor its regulation services provider accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Athena Gold Corp
2025-12-15 17:31 4mo ago
2025-12-15 12:16 4mo ago
Nutrien Stock Rallies 40% YTD: What's Behind the Upside? stocknewsapi
NTR
Key Takeaways NTR shares climbed 40.5% YTD, outperforming industry declines as fertilizer demand and pricing strengthened. Nutrien lifted its 2025 potash sales outlook to 14-14.5M tons on strong demand in key global markets. NTR posted strong Q3 2025 EBITDA and free cash flow growth, enabling dividends, buybacks and cost cuts.
Nutrien Ltd.’s (NTR - Free Report) shares have popped 40.5% so far this year, outperforming the industry’s 14.8% gain and the S&P 500’s 18.3% rise.

Price Performance of NTR vs. Industry and S&P 500Image Source: Zacks Investment Research

Let’s take a look at the factors that are driving this fertilizer maker. 

Global Fertilizer Demand Strength Supports NTR’s RallyNTR’s rally has been underpinned by a combination of favorable agricultural market conditions, effective operational execution and improving investor confidence. The key driver has been sustained global fertilizer demand — particularly for potash, nitrogen and phosphate — bolstered by expectations of strong crop production and higher input requirements in 2025, alongside tight inventories and limited new supply. 

Healthy demand from major markets such as North America, Brazil and Southeast Asia has supported firm pricing and higher sales volumes, prompting Nutrien to lift its 2025 potash sales outlook to around 14-14.5 million tons after delivering record shipment levels in the first nine months of the year. 

Nutrien is also gaining from acquisitions and the growing adoption of its digital platform. It continues expanding in Brazil and plans to use free cash flow to pursue targeted growth investments and tuck-in acquisitions across its retail business in 2025. 

Operational Leverage & Cash Flow Reinforce ConfidenceOperational performance and financial results have further strengthened investor confidence. In the third quarter of 2025, Nutrien delivered strong EBITDA growth, supported by higher fertilizer sales volumes and firmer pricing across all segments, with potash, nitrogen and retail each contributing meaningfully, reflecting improved operating leverage alongside continued portfolio optimization and cost-control initiatives. 

The company reported margin expansion and a sharp increase in free cash flow, which provided flexibility to return capital to its shareholders through dividends and share buybacks totaling well over $1 billion in the first nine months, underscoring Nutrien’s disciplined capital allocation and balance-sheet strength. 

Nutrien Advances Cost Cuts & Efficiency GainsNutrien’s cost and operational efficiency efforts are set to further support performance. The company is focused on lowering potash production costs and has implemented several strategic actions to reduce controllable expenses and improve free cash flow. With accelerated efficiency and savings initiatives, Nutrien expects to achieve about $200 million in total cost reductions in 2025 and is currently ahead of schedule on this target. 

NTR’s Zacks Rank & Key PicksNTR currently carries a Zacks Rank #3 (Hold). 

Some better-ranked stocks in the basic materials space include Agnico Eagle Mines Limited (AEM - Free Report) , Harmony Gold Mining Company Limited (HMY - Free Report)  and Paladin Energy Ltd (PALAF - Free Report) . 

The Zacks Consensus Estimate for Agnico Eagle’s current-year earnings is pegged at $7.78 per share. AEM, currently flaunting a Zacks Rank #1 (Strong Buy), surpassed the Zacks Consensus Estimate in each of the trailing four quarters, with an average earnings surprise of 12%. The company's shares have surged 115.2% year to date. You can see the complete list of today's Zacks #1 Rank stocks here.

The Zacks Consensus Estimate for HMY’s current-year earnings is pegged at $2.68 per share. HMY carries a Zacks Rank #2 (Buy) at present. The company's shares have soared 148.5% year to date. 

The Zacks Consensus Estimate for PALAF’s current-year earnings is pegged at 5 cents per share. PALAF currently carries a Zacks Rank #2. The company's shares have risen 31.7% year to date. 
2025-12-15 17:31 4mo ago
2025-12-15 12:16 4mo ago
Why Meta Stock Is A Better Investment Than Google? stocknewsapi
GOOG GOOGL META
META is Alphabet's competitor in the Interactive Media & Services sector that possesses:
2025-12-15 17:31 4mo ago
2025-12-15 12:20 4mo ago
Pennsylvania American Water Proudly Recognizes American Water Charitable Foundation 2025 Workforce Readiness Grantees Recipients stocknewsapi
AWK
Two nonprofit organizations across awarded a total of $75,000 in funds

, /PRNewswire/ -- The American Water Charitable Foundation, a philanthropic non-profit organization established by American Water (NYSE: AWK), the largest regulated water and wastewater utility company in the U.S., recently announced two organizations were awarded 2025 Workforce Readiness Grants, providing $75,000 in total funding to support communities served by Pennsylvania American Water.

"Central Montco Technical High School is grateful to the American Water Charitable Foundation and Pennsylvania American Water for their commitment to our students," said Dr. Angela King, the school's executive director about the 2025 grant it received. "Their generosity and willingness to partner with us is critical as we prepare individuals to enter the workforce or pursue post-secondary education. Workforce development requires collaboration, and the American Water Charitable Foundation, along with Pennsylvania American Water, have demonstrated that they take seriously their responsibility to help equip the next generation of highly skilled workers."

The Workforce Readiness grant is part of the American Water Charitable Foundation's Keep Communities Flowing Grant Program, focusing on three pillars of giving: Water, People and Communities. This grant program focuses on general career readiness, financial and business literacy, positive youth development and life skills training. This year's recipients in Pennsylvania include:

Central Montco Technical High School (Montgomery County) – A $25,000 grant supports the Hydroponics for Sustainable Food Supply program through which landscaping students learn about sustainable, modern agriculture through hands-on, practical experience.
Greater Wilkes-Barre Chamber of Business and Industry (Luzerne County) – A $50,000 grant supports Luzerne Learns to Work, a program that provides students with a process and platform to explore career pathways and industry pipelines.

"We believe that providing people with access to educational opportunities that allow them to grow and progress professionally is crucial to our shared success as a community," said Justin Ladner, president of Pennsylvania American Water, who also serves on the foundation's board of trustees. "To that end, I am honored to announce that two local nonprofit organizations have been awarded $75,000 in funding from the American Water Charitable Foundation to support workforce development programming. We congratulate these outstanding community partners and thank them for their efforts."

"Thanks to the support of the American Water Charitable Foundation through their Workforce Readiness Grant, our Luzerne Learns to Work program will be able to give more students meaningful opportunities to explore careers, build essential skills and connect with employers in our region," said Shanie Mohamed, director of economic development for the Greater Wilkes-Barre Chamber of Business and Industry, another recipient of 2025 grant funding. "This support helps us deepen our workforce readiness efforts and bring more hands-on experiences, skilling opportunities and scholarships directly to students. This investment strengthens not only our program, but the local workforce pipeline – ensuring students see real possibility for their future right here at home. We truly appreciate this investment in our shared vision."

"The American Water Charitable Foundation is proud to partner with eligible nonprofit organizations across Pennsylvania," said Carrie Williams, president of the American Water Charitable Foundation. "We are thrilled to support initiatives that provide access to high-quality training and skills development for future leaders in the workplace."

Learn more about Pennsylvania American Water's community impact here.

About American Water 
American Water (NYSE: AWK) is the largest regulated water and wastewater utility company in the United States. With a history dating back to 1886, We Keep Life Flowing® by providing safe, clean, reliable and affordable drinking water and wastewater services to more than 14 million people with regulated operations in 14 states and on 18 military installations. American Water's 6,700 talented professionals leverage their significant expertise and the company's national size and scale to achieve excellent outcomes for the benefit of customers, employees, investors and other stakeholders.

For more information, visit amwater.com and join American Water on LinkedIn, Facebook, X and Instagram.

About Pennsylvania American Water
Pennsylvania American Water, a subsidiary of American Water, is the largest regulated water utility in the state with 1,200 dedicated employees working to provide safe, clean, reliable and affordable water and wastewater services to approximately 2.4 million people.

About American Water Charitable Foundation
The American Water Charitable Foundation, a philanthropic non-profit organization established by American Water, focuses on three pillars of giving: Water, People, and Communities. Since 2012, the Foundation has invested more than $20 million in funding through grants and matching gifts to support eligible organizations in communities served by American Water. The Foundation is funded by American Water shareholders and has no impact on customer rates. For more information, visit amwater.com/awcf.

SOURCE American Water
2025-12-15 17:31 4mo ago
2025-12-15 12:21 4mo ago
Macerich Stock Rises 16.2% in 6 Months: Will the Trend Last? stocknewsapi
MAC
Key Takeaways MAC has gained 16.2% in six months, beating the industry's 1.9% decline on strong portfolio fundamentals.Macerich's premium malls in affluent U.S. markets support cash flows.MAC is recycling capital, shedding non-core assets to invest in higher-growth properties.
Shares of The Macerich Company (MAC - Free Report) have gained 16.2% over the past six months, outperforming the industry's 1.9% decline.

This retail real estate investment trust (REIT) enjoys a portfolio of premium shopping centers in the United States. Its focus on omnichannel retailing is likely to support its long-term growth. The aggressive capital-recycling program will lower its leverage and enable it to invest in higher-growth properties.

Image Source: Zacks Investment Research

Let us decipher the possible factors behind the surge in the stock price for this Zacks Rank #3 (Hold) company.

Macerich has a high concentration of premium malls in vibrant U.S. markets. These properties are located in densely populated areas, where affluent consumers with significant disposable incomes live, offering the company a solid scope to generate decent cash flows. We expect MAC’s total revenues to increase by 12.7% in 2025.

Macerich has been making efforts to enhance its asset quality as well as customer relationships through increasing the adoption of the omnichannel model. The omnichannel business model has become crucial among several retail stores that are resorting to fulfilling orders out of their mall-based stores.

Further, Macerich’s shift toward reuse and mixed-use properties through recapturing and repositioning of anchor tenants remains a key emphasis. Bringing brands to new markets at its mall attracts shoppers.

Macerich has been focusing on an aggressive capital-recycling program. It involves the divestiture of non-core and slower-growth assets and the use of the proceeds to increase its presence in core markets and invest in higher-growth properties through acquisitions, developments and redevelopment initiatives.
With the above-mentioned factors, the rising trend in the stock is expected to continue in the near term.

Risks Likely to Affect MAC’s Positive TrendThe growing adoption of online shopping may adversely impact the company’s market share for brick-and-mortar stores. Potential tenant bankruptcies are likely to affect Macerich’s performance in the upcoming quarters. Moreover, a substantially leveraged balance sheet and high interest expenses remain concerns.

Stocks to ConsiderSome better-ranked stocks from the retail REIT sector are Philips Edison & Company (PECO - Free Report) and EPR Properties (EPR - Free Report) , each currently carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

The Zacks Consensus Estimate for PECO’s 2025 FFO per share has moved a cent northward to $2.58 over the past two months.

The consensus estimate for EPR’s 2025 FFO per share has moved 3 cents upward to $5.10 over the past month.

Note: Anything related to earnings presented in this write-up represents FFO, a widely used metric to gauge the performance of REITs.
2025-12-15 17:31 4mo ago
2025-12-15 12:21 4mo ago
Fannie, Freddie Expand Portfolios Ahead of Possible Public Offering stocknewsapi
FMCC FNMA
Fannie Mae and Freddie Mac have added billions of dollars of mortgage-backed securities and home loans to their balance sheets in recent months, fueling speculation they could be preparing for a potential public offering. Bloomberg's Scott Carpenter reports.
2025-12-15 17:31 4mo ago
2025-12-15 12:22 4mo ago
TPM by S&P Global to Convene Shipping and Supply Chain Leaders in California, March 1-4 stocknewsapi
SPGI
Global logistics leaders meet to address unprecedented margin pressure, rising tariff costs and supply chain disruption
Keynote by Janet Yellen, former U.S. Treasury Secretary and Federal Reserve Chair

, /PRNewswire/ -- The 26th annual TPM, S&P Global's premier shipping and supply chain conference organized by the Journal of Commerce, will bring together senior decision-makers from across the global logistics ecosystem March 1 – 4 in Long Beach, California.

TPM26: Taking Costs Out, Putting Value In underscores the urgent challenge facing shippers as rising tariff burdens drive a renewed focus on cost savings and risk mitigation—without sacrificing resilience or service quality. According to S&P Global Market Intelligence, average U.S. tariff rates now exceed 17%, up from just 2.4% a year ago, highlighting the mounting pressure on importers to uncover meaningful cost-reduction opportunities across their supply chains. This year's agenda will spotlight practical strategies for margin protection, smarter sourcing, and risk-aware cost optimization amid high tariffs and ongoing supply chain volatility.

"TPM has always been where the global container shipping industry convenes to build relationships, gain insight, and chart a path forward," said Peter Tirschwell, Vice President for Maritime & Trade at S&P Global Market Intelligence and Founder and Chairman of TPM. "As we move into 2026, TPM continues to be about people and relationships — about the essential trust, collaboration, and innovation that keeps supply chains moving in an unpredictable world." 

Keynote address and confirmed speakers

The conference will open with a keynote conversation featuring Janet L. Yellen, former U.S. Secretary of the Treasury and Chair of the Federal Reserve, in dialogue with Carlos Pascual, Senior Vice President and Head of Geopolitics and International Affairs at S&P Global Energy.

Additional speakers confirmed so far include;

Paul Gruenwald, Global Chief Economist at S&P Global Ratings;
Rolf Habben Jansen, CEO of Hapag-Lloyd;
Johan Sigsgaard, Executive Vice President of Maersk;
Ryan Peterson, CEO of Flexport;
Oscar de Bok, CEO of DHL Global Forwarding;
Jens Drewes, CEO of Hellmann Worldwide
Jeremy Nixon, CEO of Ocean Network Express
Rahul Kapoor, Global Head of Shipping Research and Analytics, S&P Global Energy

Event highlights

TPM26 features the return of TPM Academy, a series of 45-minute educational workshops led by subject matter experts with topics ranging from strategies to minimize tariff burdens, the potential impact of AI on supply chains, and the practicalities of near-shoring in the current tariff landscape. Further sessions and events across TPM26 delve into the global economic and trade outlook, the implications of China's diversification of exports away from the U.S., and an exploration of trade and maritime policy trends heading into 2026. 

The full TPM26 program can be found here, and the confirmed speaker list here.

Media Accreditation

Media registration is now open. Members of the press interested in attending TPM26 can apply for accreditation here.

Media Contacts:

Hannah Brook
S&P Global Market Intelligence  
London
+44(0)7483 439812
[email protected]
[email protected]  

Spencer Umbeck
S&P Global Market Intelligence
Kansas City
M: +1(303) 874-0754
[email protected]
[email protected] 

About S&P Global

S&P Global (NYSE: SPGI) provides Essential Intelligence. We enable governments, businesses and individuals with the right data, expertise and connected technology so that they can make decisions with conviction. From helping our customers assess new investments to guiding them through sustainability and energy transition across supply chains, we unlock new opportunities, solve challenges and Accelerate Progress for the world.

We are widely sought after by many of the world's leading organizations to provide credit ratings, benchmarks, analytics and workflow solutions in the global capital, commodity and automotive markets. With every one of our offerings, we help the world's leading organizations plan for tomorrow, today. For more information, visit www.spglobal.com

About TPM 

TPM, organized by The Journal of Commerce within S&P Global Market Intelligence, is S&P Global's premier conference focused on global ocean container supply chains. Founded in 2001, TPM is the world's largest container shipping gathering, based on an editorially independent and rigorous program developed by the Journal of Commerce, the leading team of specialized, subject matter expert journalists covering international transportation and logistics. TPM annually presents the industry's most in-depth program, delving into the most pressing challenges affecting retailers, manufacturers and other cargo owners globally. The event annually attracts the most senior-level audience in the global container shipping community, and is a platform for a week of essential and intensive networking, negotiations, and relationship building among the multiple parties in the supply chain: shippers, carriers, forwarders, technology providers, trucking operators, railroads, ports, terminals, and many others who participate in this market. 

SOURCE S&P Global
2025-12-15 17:31 4mo ago
2025-12-15 12:22 4mo ago
Nasdaq Index: Tech and AI Stocks Slide as Broadcom Weakness Hits US Indices stocknewsapi
AVGO
Important DisclaimersFXEmpire is owned and operated by Empire Media Network LTD., Company Registration Number 514641786, registered at 7 Jabotinsky Road, Ramat Gan 5252007, Israel. The content provided on this website includes general news and publications, our personal analysis and opinions, and materials provided by third parties. This content is intended for educational and research purposes only. It does not constitute, and should not be interpreted as, a recommendation or advice to take any action, including making any investment or purchasing any product. Before making any financial decision, you should conduct your own due diligence, exercise your own discretion, and consult with competent advisors. The content on this website is not personally directed to you, and we do not take into account your individual financial situation or needs. The information contained on this website is not necessarily provided in real time, nor is it guaranteed to be accurate. Prices displayed may be provided by market makers and not by exchanges. Any trading or other financial decision you make is entirely your own responsibility, and you must not rely solely on any information provided through the website. FXEmpire does not provide any warranty regarding the accuracy, completeness, or reliability of any information contained on the website and shall bear no responsibility for any trading losses you may incur as a result of using such information. The website may include advertisements and other promotional content. FXEmpire may receive compensation from third parties in connection with such content. FXEmpire does not endorse, recommend, or assume responsibility for the use of any third-party services or websites. Empire Media Network LTD., its employees, officers, subsidiaries, and affiliates shall not be liable for any loss or damage resulting from your use of the website or reliance on the information provided herein.Risk DisclaimersThis website contains information about cryptocurrencies, contracts for difference (CFDs), and other financial instruments, as well as about brokers, exchanges, and other entities trading in such instruments. Both cryptocurrencies and CFDs are complex instruments and involve a high risk of losing money. You should carefully consider whether you understand how these instruments work and whether you can afford to take the high risk of losing your money. FX Empire encourages you to conduct your own research before making any investment decision and to avoid investing in any financial instrument unless you fully understand how it works and the risks involved.
2025-12-15 17:31 4mo ago
2025-12-15 12:26 4mo ago
Kuehn Law Encourages Investors of Skye Bioscience, Inc. to Contact Law Firm stocknewsapi
SKYE
New York, New York--(Newsfile Corp. - December 15, 2025) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Skye Bioscience, Inc. (NASDAQ: SKYE) breached their fiduciary duties to shareholders.

According to a federal securities lawsuit, Insiders at Skye Bioscience caused the company to misrepresent or fail to disclose that: (i) nimacimab was less effective than represented; (ii) accordingly, nimacimab's clinical, regulatory, and commercial prospects were overstated; and (iii) as a result, public statements were materially false and misleading at all relevant times.

If you currently own SKYE and purchased prior to November 4, 2024 please contact Justin Kuehn, Esq. by email at [email protected] or call (833) 672-0814. Kuehn Law pays all case costs and does not charge its investor clients. Shareholders should contact the firm immediately as there may be limited time to enforce your rights.

Why Your Participation Matters:

As a shareholder your voice matters, and by getting involved, you contribute to the integrity and fairness of the financial markets. Your investment. Your voice. Your future.™

For additional information, please visit Shareholder Derivative Litigation - Kuehn Law.

Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts:
Kuehn Law, PLLC
Justin Kuehn, Esq.
53 Hill Street, Suite 605
Southampton, NY 11968
[email protected]
(833) 672-0814

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/278072

Source: Kuehn Law, PLLC

Ready to Announce with Confidence?
Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us
2025-12-15 17:31 4mo ago
2025-12-15 12:26 4mo ago
Albemarle and Power Metals Sign Cesium Concentrate Offtake Deal stocknewsapi
ALB
Key Takeaways ALB entered a C$5M pre-payment deal to acquire cesium oxide concentrate and offtake rights for Case Lake.Power Metals' Case Lake hosts near-surface, high-grade cesium, strengthening North America's supply chain.Albemarle's payments are staged- C$2M on execution and C$3M after environmental approval to mine.
Albemarle Corporation (ALB - Free Report) has entered into a cesium concentrate offtake agreement with Power Metals Corp. Under the agreement, ALB has agreed to a pre-payment of C$5 million to Power Metals Corp for cesium oxide concentrate from the latter’s Case Lake Project located in Ontario, Canada. The deal involves ALB's purchase of the current offtake rights held by Winsome Resources in the project.

The Case Lake Project has been of growing strategic importance as it hosts near-surface, high-grade cesium and has the potential to play a significant role in securing North America’s cesium supply chain. While the project’s offtake rights are being assigned to ALB, Winsome will retain its 15.8% shareholding of Power Metals. Albemarle’s participation strengthens Power Metals’ Canadian critical minerals strategy by securing downstream expertise in high-value cesium chemicals and supporting the development of an integrated cesium market.

The transfer of offtake rights from Hong Kong-based Sinomine Resources Limited to Winsome Resources and now, Albemarle marks a shift in the global critical-minerals landscape as the focus on securing the North American supply chain increases.

The pre-payment is subject to Power Metals securing the necessary approvals and permits to commence mining at Case Lake. It has laid out financing in stages as key development milestones are achieved, with the first portion amounting to C$2M paid following execution of the pre-payment commitment and the second C$3M paid on delivery of Environmental Compliance Approval for the Case Lake Project in 2026.  

ALB’s shares have gained 36.1% over the past year compared with the industry’s 17% decline.

Image Source: Zacks Investment Research

ALB’s Zacks Rank & Key PicksALB currently carries a Zacks Rank #3 (Hold).

Some better-ranked stocks in the Basic Materials space are Kinross Gold Corporation (KGC - Free Report) , Fortuna Mining Corp. (FSM - Free Report) and Harmony Gold Mining Company Limited (HMY - Free Report) .

At present, KGC sports a Zacks Rank #1 (Strong Buy), while FSM and HMY carry a Zacks Rank #2 (Buy) each. You can see the complete list of today’s Zacks #1 Rank stocks here.

The Zacks Consensus Estimate for KGC’s current-year earnings is pegged at $1.67 per share, indicating a rise of 145.59%. Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters while missing it in one, with an average surprise of 17.37%. KGC’s shares have risen 188.2% over the past year.

The Zacks Consensus Estimate for FSM’s current fiscal-year earnings is pinned at 76 cents per share, indicating a 65.22% year-over-year increase. Its shares have surged 110.8% over the past year.

The Zacks Consensus Estimate for HMY’s 2026 earnings is pegged at $2.68 per share, indicating a 132.1% year-over-year increase. HMY’s shares have gained 133.9% over the past year.
2025-12-15 17:31 4mo ago
2025-12-15 12:26 4mo ago
Reasons Why You Should Hold Trane Technologies Stock for Now stocknewsapi
TT
Key Takeaways TT posts strong growth outlook, with 2025 earnings expected to be up 16% and revenues likely to rise 7.1% y/y.TT's Commercial HVAC momentum drives results, with applied bookings hitting all-time highs, up 30% y/y.TT boosts value via Brainbox AI, while navigating intense competition across global HVAC markets.
Trane Technologies (TT - Free Report) has a Growth Score of A. This style score condenses key financial metrics to reflect a fair sense of the quality and sustainability of its growth.

The company’s fourth-quarter 2025 earnings are expected to be up 8% year over year. Earnings for 2025 and 2026 are expected to rise 16% and 13.8%, respectively, year over year. Revenues are expected to increase 7.1% in 2025 and 7.7% in 2026.

Factors That Augur Well for TTTrane Technologies’ business is primarily driven by the Commercial HVAC (Heating, Ventilation and Air Conditioning) market. According to Grand View Research, the market size is nearly $259 billion in 2025. With its doubled applied bookings, it reached an all-time high, surging 30% year over year in the last reported quarter.

The company’s recent acquisition, Brainbox AI, adds considerable value to the HVAC services provided to buildings. As the green environment drive grows globally, this Agentic AI leverages organizations to achieve measurable reductions in energy consumption, long-term efficiency and sustainability by lowering their carbon emissions.

The company remains committed to creating long-term value for its investors. It consistently rewards its shareholders through dividend payments and share repurchases. It paid $561.1 million, $620 million, $683.7 million and $757.5 million in dividends and repurchased shares worth $1.1 billion, $1.2 billion, $669.3 million and $1.3 billion in 2021, 2022, 2023 and 2024, respectively.

Although below the industry average of 1.58, its current ratio (a measure of liquidity) of 1.21 in the third quarter of 2025 was up from 1.1 in the previous quarter due to an increase in cash reserves. A current ratio of above 1 will assist the company in paying off short-term obligations efficiently.

A RiskTT operates in a competitive market, with giants including Honeywell International, Siemens, Carrier and Daikin Industries. This competition increases the difficulty in balancing growth and profitability while continuously innovating and differentiating its offerings and maintaining cost efficiency.

Zacks Rank & Stocks to Consider

Trane Technologies currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here

A couple of better-ranked stocks in the industry are Gen Digital (GEN - Free Report)  and Jamf Holding  (JAMF - Free Report) .

Gen Digital carries a Zacks Rank #2 (Buy) at present. It has a long-term earnings growth expectation of 13.1%.

GEN delivered a trailing four-quarter earnings surprise of 3% on average.

Jamf Holding carries a Zacks Rank of 2 at present. It has a long-term earnings growth expectation of 17.3%.

JAMF delivered a trailing four-quarter earnings surprise of 9.4% on average.
2025-12-15 17:31 4mo ago
2025-12-15 12:26 4mo ago
Can IREN Sustain Growth Amid Its Rapidly Mounting Capex Burden? stocknewsapi
IREN
Key Takeaways IREN is rapidly scaling AI cloud operations with plans for 140,000 GPUs and major site upgrades by 2026.IREN's capital requirements are rising, with multibillion-dollar capex far outpacing operating cash flow.IREN is leaning on external funding as revenue is projected to climb 116.4% in 2026 on rising AI demand.
IREN Limited’s (IREN - Free Report) shift toward AI cloud infrastructure boosts long-term prospects while sharply increasing capital intensity. The company has highlighted massive capital needs that will significantly impact its long-term financial trajectory.

IREN plans to deploy 140,000 GPUs by 2026 and upgrade multiple sites with liquid cooling, Tier-3 standards and high-density rack infrastructure. These initiatives span several years and involve multibillion-dollar investments. The Microsoft partnership alone requires $5.8 billion in GPU capital expenditure, while extensive build-outs at Childress (750 MW), British Columbia and the 2 GW Sweetwater hub further increase spending needs.

This rapid scaling has pushed capex far beyond internally generated cash. In the first quarter of fiscal 2026, IREN reported a strong operating cash flow of $142.4 million; however, investing outflows totalled $280.9 million. Heavy spending on property and equipment ($180.3 million) and GPU prepayments (over $100 million) underscores the persistent capital strain. To bridge the gap, the company increasingly depends on external financing, including Microsoft prepayments, GPU funding facilities and $1.0 billion in convertible note issuance.

Despite these challenges, the growth potential is attractive. The Zacks Consensus Estimate forecasts 116.4% revenue growth in 2026, reaching $1.10 billion — an indication that rising AI demand may ultimately justify the upfront investment. With specific implementation, current capital expenditure growth can develop into a strong foundation for future AI cloud profitability.

How IREN Compares With Key Industry RivalsCleanSpark (CLSK - Free Report) and Applied Digital (APLD - Free Report) are key competitors making significant CapEx investments in AI infrastructure & High-Performance Computing (HPC).

CleanSpark is using its energy, land and management expertise to build AI/HPC-ready campuses with liquid-cooled, GPU-optimized infrastructure. Unlike IREN, CleanSpark stands out for its rapid commercial implementation, strong fiscal year 2025 revenue growth, a large contracted power pipeline and $1.15 billion in targeted capital activities. The company benefits from proven site development and energy management, although leverage and integration risks remain. Overall, CleanSpark's diversified, infrastructure-first strategy contrasts with IREN's concentrated AI hardware approach.

Applied Digital has repositioned itself from crypto hosting to purpose-built AI and HPC data centers, competing directly with IREN for hyperscaler and enterprise GPU workloads. The company designs and operates AI/HPC-first campuses like Polaris Forge, which offer high power density, liquid cooling and scalable layouts. Backed by long-term leases, including a 15-year, $11 billion CoreWeave contract, Applied Digital has distinguished itself from the start with a hyperscaler-focused, energy-efficient infrastructure.

IREN’s Price Performance, Valuation & EstimatesShares of IREN have soared 188.5% in the past year, outperforming the broader Zacks Finance sector’s return of 13.7% and the Zacks Financial Miscellaneous Services industry’s decline of 12%.

IREN’s One-Year Price Performance
Image Source: Zacks Investment Research

IREN shares are overvalued, as suggested by the Value Score of F. In terms of forward price/sales, IREN is trading at 6.78X compared with the industry’s 3.36X.

IREN’s Valuation
Image Source: Zacks Investment Research

The Zacks Consensus Estimate for IREN’s fiscal 2026 earnings is pegged at 79 cents per share, marking a sharp year-over-year improvement from just 4 cents. However, the fiscal 2027 earnings estimate of 34 cents indicates a year-over-year decline of 56.33%. Notably, consensus estimates for both fiscal 2026 and 2027 have remained unchanged over the past 30 days, indicating stable near-term expectations.

Image Source: Zacks Investment Research
2025-12-15 17:31 4mo ago
2025-12-15 12:26 4mo ago
Is Applied Digital Stock Still a Buy After 141% Surge in 6 Months? stocknewsapi
APLD
Key Takeaways APLD's Polaris Forge 1 campus is backed by a full 400MW CoreWeave commitment, boosting multi-year revenue.APLD's capital structure supports growth, with preferred equity and project financing in place.The Zacks Consensus Estimate pegs APLD's fiscal 2026 revenues at $280.9M, up 30.35% year over year.
Applied Digital (APLD - Free Report) shares have appreciated 141.2% in the past six months, outperforming the broader Zacks Finance sector’s increase of 10.7% and the Zacks Financial – Miscellaneous Services industry’s fall of 1.6%. During the same period, Equinix (EQIX - Free Report) has declined 15.5%, while Riot Platforms (RIOT - Free Report) has jumped 50.5%, highlighting APLD’s outsized relative performance within the digital infrastructure space.

The rally reflects rising investor confidence in APLD's shift from a speculative infrastructure developer to a contracted hyperscale data centre operator. The expanded CoreWeave (CRWV - Free Report) lease at Polaris Forge 1 has strengthened long-term revenue visibility, while early progress at Polaris Forge 2 reinforces APLD’s positioning in AI infrastructure.

APLD’s Price Performance
Image Source: Zacks Investment Research

With the stock sharply re-rated, does APLD still offer upside at current levels, or is much of the optimism already priced in? Let’s delve deeper to find out.

Contracted Revenue Visibility Provides FoundationApplied Digital’s long-term revenue visibility is anchored by its arrangements with CoreWeave, representing $11 billion in contracted lease revenues tied to the full 400-megawatt commitment at Polaris Forge 1. This provides a multi-year outlook as the first 100-megawatt building approaches readiness and transitions into recurring lease revenue. CoreWeave’s engagement for tenant fit-out services also supports near-term activity, helping bridge the period between construction and lease monetisation.

With a substantial portion of capacity already committed under long-duration agreements, APLD is positioned to move toward a more predictable, infrastructure-style revenue mix as additional phases come online. Progress at Polaris Forge 2 extends this visibility beyond the initial campus, reinforcing confidence in APLD’s ability to replicate its contracted model. Once Polaris Forge 1 reaches full operation, the campus is expected to support approximately $500 million in annual net operating income, underscoring the scale of the financial inflection. The Zacks Consensus Estimate for fiscal 2026 revenues is pegged at $280.9 million, reflecting a 30.35% year-over-year increase.

APLD’s Strategic Positioning in AI InfrastructureThe acceleration of artificial intelligence adoption has triggered an unusually concentrated wave of infrastructure investment, with hyperscalers committing substantial capital toward AI-ready data centers. This shift has elevated demand for developers that can deliver power-dense, purpose-built facilities at speed, rather than traditional colocation capacity. APLD is well-positioned to benefit from this constrained supply environment.

APLD’s active development pipeline spans roughly 4 gigawatts, with 700 megawatts currently under construction, providing meaningful scale relative to its size. APLD has shortened construction timelines to approximately 12–14 months from nearly 24 months, improving alignment with hyperscaler deployment schedules. Beyond its existing CoreWeave relationship, APLD is engaged in discussions with additional hyperscalers for new sites. Progress at Polaris Forge 2 near Harwood, ND, further reinforces this positioning, with the 300-megawatt campus designed to scale toward 1 gigawatt, aligning capacity expansion with long-term AI infrastructure demand.

Financial Structure Supports ExpansionAPLD’s capital structure supports expansion while limiting reliance on frequent equity issuance. In October 2025, the company drew $112.5 million from its $5 billion preferred equity facility with Macquarie Asset Management to fund construction at Polaris Forge 1. When combined with project financing, this structure unlocks an estimated $20–25 billion in capital capacity, positioning APLD to advance multiple campuses in parallel.

Project financing for Polaris Forge 1 is expected to close during the second quarter of fiscal 2026 with approximately 70% loan-to-cost ratios. APLD secured $50 million in initial funding from Macquarie Equipment Capital for the $3 billion Polaris Forge 2 development. This financial architecture allows APLD to scale in line with the accelerated deployment timelines required by hyperscale customers building compute capacity for next-generation AI workloads.

For fiscal 2026, the Zacks Consensus Estimate for loss is pegged at 31 cents per share, improving from the year-ago loss of 80 cents per share, with estimates improving 5cents over the past 60 days.

Valuation Reflects Early-Stage MonetisationApplied Digital stock trades at a forward 12-month price-to-sales (P/S) of 18.43X, well above the Zacks industry average of 3.35X and the broader sector’s multiple of 9.07X. APLD also commands a premium to peers such as Riot Platforms and Equinix, which trade at P/S multiples of 7.79X and 7.37X, respectively.

While the valuation gap versus Riot Platforms and Equinix appears wide, it reflects APLD’s earlier position in the monetisation cycle. The market is valuing contracted hyperscale demand and future NOI generation rather than current utilisation. As Polaris Forge assets move into operation, revenue recognition is expected to accelerate, supporting the premium valuation.

APLD’s P/S F12M Ratio
Image Source: Zacks Investment Research

ConclusionAPLD’s sharp rally over the past six months reflects a fundamental re-rating driven by improving revenue visibility, scalable AI-focused infrastructure and a capital structure that supports disciplined expansion. While the stock trades at a premium, the valuation is supported by long-duration hyperscale contracts and a clear path toward recurring net operating income as Polaris Forge assets come online. With monetisation still in the early stages, investors can consider buying APLD at current levels.

Applied Digital carries a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
2025-12-15 17:31 4mo ago
2025-12-15 12:26 4mo ago
Profit taking tempers early gold gains; silver solidly up stocknewsapi
AAAU BAR DBP DGL GLD GLDM IAU OUNZ SGOL SIL SILJ SIVR SLV SLVP UGL
Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financial journalist with the FWN newswire service for many years, including stints as a reporter on the rough-and-tumble commodity futures trading floors in Chicago and New York. As a journalist, he has covered every futures market traded in the U.S., at one time or another.

Jim is the proprietor of the "Jim Wyckoff on the Markets" analytical, educational and trading advisory service. Jim also worked as a technical analyst for Dow Jones Newswires and as the senior market analyst with TraderPlanet.com. Jim is also a consultant with the highly respected "Pro Farmer" agricultural advisory service. Jim was also the head equities analyst at CapitalistEdge.com. He received his degree from Iowa State University in Ames, Iowa, where he studied journalism and economics.

Follow Jim daily on Kitco.com as he provides both AM and PM roundups and a daily Technical Special.
1 877 963-NEWS
jwyckoff at kitco.com
2025-12-15 17:31 4mo ago
2025-12-15 12:29 4mo ago
Westlake Corporation (WLK) Discusses Facility Closures and Profitability Improvement Actions in Performance and Essential Materials Segment Transcript stocknewsapi
WLK
Westlake Corporation (WLK) Discusses Facility Closures and Profitability Improvement Actions in Performance and Essential Materials Segment December 15, 2025 10:00 AM EST

Company Participants

Jeff Holy - VP & Chief Accounting Officer
Jean-Marc Gilson - President & CEO
M. Bender - Executive VP & CFO

Conference Call Participants

Patrick Cunningham - Citigroup Inc., Research Division
Arun Viswanathan - RBC Capital Markets, Research Division
Patrick Fischer - Goldman Sachs Group, Inc., Research Division
Aleksey Yefremov - KeyBanc Capital Markets Inc., Research Division
Michael Sison - Wells Fargo Securities, LLC, Research Division
Salvator Tiano - BofA Securities, Research Division
Joshua Spector - UBS Investment Bank, Research Division
David Begleiter - Deutsche Bank AG, Research Division
Jeffrey Zekauskas - JPMorgan Chase & Co, Research Division
Kevin McCarthy - Vertical Research Partners, LLC

Presentation

Operator

Good morning, ladies and gentlemen. Thank you for standing by. Welcome to the Westlake Corporation PEM Profitability Improvement Plan Update Conference Call. [Operator Instructions]. As a reminder, ladies and gentlemen, this conference is being recorded today, December 15, 2025. I would now like to turn the call over to today's host, Jeff Holy, Westlake's Vice President and Chief Accounting Officer. Sir, you may begin.

Jeff Holy
VP & Chief Accounting Officer

Thank you, Daniel. Good morning, everyone, and welcome to the Westlake Corporation conference call to provide an update on our PEM Profitability Improvement Plan.

I'm joined today by Jean-Marc Gilson, our President and CEO; Steve Bender, our Executive Vice President and Chief Financial Officer, and other members of our management team. During this call, we will refer to our 2 reporting segments: Performance and Essential Materials, which we refer to as PEM or Materials; and Housing and Infrastructure Products, which we refer to as HIP or Products. Today's conference call will begin with Jean-Marc, who will open with a few comments regarding today's announcement. Steve will then provide a summary of some of the key financial and operating impacts of
2025-12-15 17:31 4mo ago
2025-12-15 12:30 4mo ago
Tempus AI Near $75 Target? Valuation, Upside and Risks stocknewsapi
TEM
Key Takeaways TEM trades near $70.61 against a $75 target, with upside tied to execution and regulatory progress.Valuation implies 8.6x forward sales, hinging on pricing and reimbursement improvement into 2026.Genomics growth, data bookings, and regulatory milestones will drive margin and EBITDA gains.
Tempus AI (TEM - Free Report) has rallied hard in 2025 and now trades close to its 6–12 month target. Progress from regulators and steady execution will be key.

The trend is strong, but slow booking-to-revenue conversion and ongoing GAAP losses suggest patience on new entries.

Where Shares Trade Versus ObjectiveShares recently changed hands at $70.61 against a 6–12 month target of $75, leaving modest upside from current levels as execution and approvals unfold. TEM carries a Zacks Rank #3 (Hold). Zacks Style Scores are mixed, with Value F, Growth C and Momentum B.

Year to date, TEM is up 104.9%, well ahead of the subindustry, sector and the S&P 500. The remaining upside to the target therefore, hinges on catalysts translating into better pricing and margin progress.

YTD Price Performance
Image Source: Zacks Investment Research

How the Multiple Stacks UpTEM trades at 8.1x forward 12-month sales versus 4.8x times for the sub-industry, 2.2x for the sector and 5.3x for the S&P 500. Over the past year, the range has been 4.9x–16.5x with a 1-year median of 8.1x. That premium places a higher bar on delivery.

The stock’s advance has widened valuation spreads versus peers, yet the target embeds 8.6 times forward sales, suggesting room for upside if pricing and reimbursement steadily improve as management executes.

Catalysts That Could Support the CaseRegulatory pricing catch-up is crucial. Management plans to migrate a majority of xT CDx test volume onto the Advanced Diagnostic Laboratory Test pathway through 2026 and expects to file for xT in vitro diagnostic approval by year-end 2025, with xF to follow. These steps, together with assay-by-assay approvals, support better average selling prices over time. Minimal residual disease reimbursement is “on track,” with gradual quarterly ramp anticipated.

Beyond pricing, the diagnostics engine continues to expand. Genomics revenue more than doubled year over year through the first nine months of 2025 on oncology volume and hereditary testing gains, while the Data and Services line posted double-digit growth on larger, multi-year agreements. Expanding data bookings enhance visibility and can drive operating leverage if conversion remains on schedule.

Execution and Conversion Risks to MonitorThe average selling price (ASP) remains below peers until approvals are completed, and the timing rests on regulatory reviews that can face delays. Until then, unit economics trail competitors.

Data bookings convert over multi-year periods and are typically second-half weighted, which can create quarterly volatility and mask underlying demand. GAAP losses persist as the company invests in compute, regulatory, and integration initiatives, while competition and integration complexity add execution risk.

What the Short-Term Rating Signals NowThe Zacks Rank #3 (Hold) and mixed Style Scores indicate balanced near-term risk-reward after the sharp year-to-date move. For investors looking to initiate exposure, pullbacks or confirmation on regulatory filings and minimal residual disease reimbursement milestones may provide better risk-managed entry points.

Investors comparing across medical information systems may also watch Doximity (DOCS - Free Report) and 10x Genomics (TXG - Free Report) . Both are listed among industry peers with Zacks Rank #3 (Hold), offering alternative ways to participate while awaiting TEM’s milestone execution.

Key Numbers to Track into 2026Management now expects 2025 revenue of approximately $1.27 billion for the consolidated business. Adjusted EBITDA is guided to about $20 million for the current year, with continued cost discipline and sales-force efficiency post integration.

Image Source: Zacks Investment Research

Our forward 12-month earnings per share consensus anticipates improving results through 2026 and a potential positive print in 2027. Monitoring revenue cadence, pricing uplift from Advanced Diagnostic Laboratory Test migrations and in vitro diagnostic approvals, the minimal residual disease reimbursement ramp and EBITDA progression will be central to the path toward sustained profitability. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
2025-12-15 17:31 4mo ago
2025-12-15 12:30 4mo ago
Here's Why RenaissanceRe Shares Are Attracting Prudent Investors Now stocknewsapi
RNR
Key Takeaways RNR stock rose 10% in 6 months, outperforming the industry's 1.5% gain on stronger premiums and income growth.RNR's 2025 earnings estimate rose to $34.61 per share, with two upward revisions in the past 30 days.RNR boosted scale and profitability with the Validus Re acquisition and continues heavy share buybacks.
RenaissanceRe Holdings Ltd. (RNR - Free Report) primarily provides property, casualty and specialty reinsurance and certain insurance solutions to its customers. The company operates via two reportable segments: Property, and Casualty and Specialty. Also, it has an Other category, which mainly comprises its investment unit. In the past six months, shares of RNR have grown 10%, outperforming the industry’s 1.5% rise.

RenaissanceRe — with a market capitalization of $12.6 billion — is well-poised to grow, backed by its increasing premium, investment income, cash generation ability and strategic acquisitions and partnerships. The rise in returns from the fixed maturity portfolio and improving underwriting results add further momentum.

Courtesy of solid prospects, this Zacks Rank #1 (Strong Buy) stock is worth adding to your portfolio at the moment.

Let’s delve deeper.

Where Do RNR’s Estimates Stand?The Zacks Consensus Estimate for RenaissanceRe’s 2025 earnings is pegged at $34.61 per share and has witnessed two upward estimate revisions in the past 30 days against none in the opposite direction. Furthermore, the consensus mark for revenues is pegged at $12.2 billion for 2025, indicating 3.4% year-over-year growth. It beat earnings estimates in three of the past four quarters and missed once.

RNR’s Growth DriversRenaissanceRe has benefited from strong momentum in net premiums earned, thanks to growth across both of its segments. The metric grew 35.1% in 2024 and remained stable year over year in the first nine months of 2025. Its total revenues rose 5% year over year in the first nine months of 2025. We expect the metric to increase 9.8% year over year in 2025. Strong underwriting results contribute to profit growth, which is evident in recent upward estimate revisions.

RenaissanceRe's acquisition of Validus Re and related businesses from AIG enhanced the scale of its global property and casualty reinsurance business and boosted profitability. The company also optimizes its portfolio by divesting non-core assets. RNR expects continued opportunities to build an attractive portfolio at the Jan. 1, 2026, renewal through early client engagement, careful risk selection and differentiated structuring. Its net investment income increased 2.6% year over year in the first three quarters of 2025.

RNR’s robust cash generation abilities have enabled it to continue elevating shareholder value through share buybacks and dividend payouts. In the first nine months of 2025, the company rewarded its shareholders with share buybacks of $939.6 million. Additionally, from Oct. 1 to Oct. 24, 2025, it repurchased shares worth $100 million again. In November 2025, management approved a renewal of RenaissanceRe’s share repurchase program, increasing the total authorization to $750 million. This amount includes the remaining funds from previous authorizations.

Moreover, RNR is currently trading at a discount compared to the industry average. The stock is currently trading at 1.17X, trailing 12-month tangible book value, which compares to 1.51X for the industry, indicating undervaluation. The company has a Value Score of B.

Risks for RNR StockThere are some factors, however, that investors should keep a careful eye on.

RenaissanceRe faces escalating expenses due to higher net claims, claim expenses and operational expenses. Total expenses rose 44.4% in 2024, followed by a 12.6% year-over-year rise in the first nine months of 2025. We expect the metric to rise 8.7% year over year in 2025. The rising expenses pose a risk to the company’s profit margins.

As of Sept. 30, 2025, RenaissanceRe carried $2.2 billion in debt, with a total debt-to-capital ratio of 16.2, above the industry average of 15.6. Elevated debt levels have driven up interest expenses, which rose 28.1% year over year in 2024 and 26.9% in the first nine months of 2025. This growing interest burden could weigh on margins.

Other Key PicksSome other top-ranked stocks in the broader finance space are The Travelers Companies, Inc. (TRV - Free Report) , Heritage Insurance Holdings Inc. (HRTG - Free Report) and The Allstate Corporation (ALL - Free Report) , each sporting a Zacks Rank #1 at present. You can see the complete list of today’s Zacks #1 Rank stocks here.

The Zacks Consensus Estimate for The Travelers Companies’ current-year earnings of $24.75 per share has witnessed 12 upward revisions in the past 60 days against none in the opposite direction. The Travelers Companies beat earnings estimates in each of the trailing four quarters, with the average surprise being 89.3%. The consensus estimate for current-year revenues is pegged at $48.8 billion, implying 5.1% year-over-year growth.

The Zacks Consensus Estimate for Heritage Insurance’s current-year earnings of $5.14 per share has witnessed two upward revisions in the past 60 days against no movement in the opposite direction. Heritage Insurance beat earnings estimates in each of the trailing four quarters, with the average surprise being 100.1%. The consensus estimate for current-year revenues is pegged at $844.6 million, calling for 3.4% year-over-year growth.

The Zacks Consensus Estimate for Allstate’s current-year earnings is pegged at $28.21 per share and has witnessed three upward revisions in the past 30 days against no movement in the opposite direction. Allstate beat earnings estimates in each of the trailing four quarters, with the average surprise being 47.3%. The consensus estimate for current-year revenues is pegged at $69 billion, calling for 7.2% year-over-year growth.
2025-12-15 16:31 4mo ago
2025-12-15 10:41 4mo ago
Tom Lee's BitMine Keeps Buying Ethereum, Adding $320 Million to ETH Treasury cryptonews
ETH
In brief
BitMine bought more than 100,000 ETH valued around $320 million last week.
The firm now owns 3.2% of the circulating ETH supply, or about $12.4 billion in total.
Ethereum and BitMine's stock price are both falling Monday.
Publicly traded Ethereum treasury firm BitMine Immersion Technologies (BMNR) added another 102,259 ETH valued around $320 million in the last week, the firm announced on Monday. 

The firm now holds 3,967,210 ETH, valued at more than $12.4 billion in ETH. It also holds 193 BTC worth around $17 million, and has $1 billion in cash. 

“BitMine continues to add steadily to its ETH holdings, adding 102,259 ETH in the past week. Crypto prices have stabilized in the past week, further evidence that crypto prices have begun to recover after the price shock of October 10th,” said BitMine Chairman Tom Lee, in a statement.

"2025 saw many positive developments in digital assets including positive legislation passed by the U.S. Congress and favorable regulations, and by strengthening support from Wall Street,” he continued. “These strengthen our conviction that the best days for crypto are ahead and why we continue to accumulate ETH towards our 'alchemy of 5%' target."

BitMine’s latest acquisition continues an aggressive string of purchases in which the firm has added to its position as the leading ETH treasury firm, amid wobbling ETH prices. 

In the firm’s previous purchase, disclosed last week, it bought around $429 million of ETH—its largest acquisition since October.

According to Lee, the firm is putting “its money where its mouth is,” adding that BitMine believes that ETH has already bottomed for the year. In other words, Lee and his firm think that Ethereum has already hit its lowest price point this year.

Beyond buying ETH, the firm is also making progress on a bespoke staking solution called The Made in America Validator Network (MAVAN), which will allow it to earn yield on its holdings.

In a recent video interview with Farokh Sarmad—president of Dastan, Decrypt’s parent company—Lee noted that the firm could make as much as $400 million in staking revenue annually from its holdings. 

Shares of BMNR are down nearly 7% since the opening bell on Monday, recently changing hands at $32.48. Since hitting a yearly peak of $161 on June 30, BMNR shares have now dropped nearly 80%. 

ETH is down more than 2% in the last 24 hours, recently trading hands at $3,010.

Daily Debrief NewsletterStart every day with the top news stories right now, plus original features, a podcast, videos and more.
2025-12-15 16:31 4mo ago
2025-12-15 10:43 4mo ago
Dogecoin Jumps 77% in Volume as Crucial Support Gets Tested cryptonews
DOGE
Cover image via U.Today

Disclaimer: The opinions expressed by our writers are their own and do not represent the views of U.Today. The financial and market information provided on U.Today is intended for informational purposes only. U.Today is not liable for any financial losses incurred while trading cryptocurrencies. Conduct your own research by contacting financial experts before making any investment decisions. We believe that all content is accurate as of the date of publication, but certain offers mentioned may no longer be available.

Dog-themed cryptocurrency Dogecoin is performing a crucial support test, having reached a low of $0.131 in the early Monday session.

At press time, Dogecoin was trading down 2.04% in the last 24 hours to $0.132 as the majority of cryptocurrencies traded in red following Bitcoin's drop below $90,000 over the weekend.

Dogecoin fell from a Dec. 9 high of $0.153, marking four out of five days in the red since this date. Amid the drop, the $0.14 key support level failed, with eyes on $0.13 as the next crucial short-term support level.

HOT Stories

According to CoinMarketCap data, Dogecoin trading volumes have increased 77% in the last 24 hours to $1.08 billion as traders adjusted their positioning as the market fell.

What comes next?Analysts indicate that Dogecoin might be on the verge of a textbook capitulation event as increased volume coupled with support failure might mark short-term exhaustion.

Dogecoin is now at a crossroads, with indicators highlighting a mixed bag for traders as to where it heads next.

The $0.13 psychological level is now viewed as the most important short-term support, with a sustained hold above here favoring range-trading rather than continuation. If the $0.14 level is reclaimed, Dogecoin would target $0.15 once again. Failure below $0.131 might lead to a retest of Oct. 10 flash crash low of $0.09.

On the other hand, DOGE has seen an increase in notional open interest (OI) over 24 hours, reaching 10.80 billion DOGE, the highest since Nov. 20 alongside moderately positive funding rates, offering quiet hope to bulls.
2025-12-15 16:31 4mo ago
2025-12-15 10:45 4mo ago
Bitcoin Was Supposed To Pump To $150,000 In Q4—Why Didn't It Happen? cryptonews
BTC
Bitcoin (CRYPTO: BTC) has been digesting the Trump-driven post-election surge, with price action at the end of 2025 showing correction and absorption rather than renewed upside momentum.

Post-Election Rally Runs Into Heavy SupplyThe 80% surge following the 2024 presidential election pushed Bitcoin aggressively into the $120,000 to $125,000 supply zone. 

That region marked a long-standing resistance band where price failed to establish any meaningful base.

Once momentum faded, Bitcoin rolled over quickly, breaking several short-term supports in succession. 

Daily Chart Remains Structurally Corrective

BTC Key Technical Levels (Source: TradingView)

On the daily timeframe, Bitcoin remains capped beneath a falling trendline that has guided price lower since the October peak. 

Each rebound attempt into that trendline has been rejected.

Until Bitcoin can reclaim and hold above that structure, the broader market posture remains corrective. 

The chart does not yet support a sustained bullish continuation.

Additionally, Bitcoin continues to trade below major EMAs, clustered between $95,000 and $103,000.

Those levels now represent active supply. 

Rallies into this zone have been met with selling, indicating that traders are using strength to reduce exposure rather than chase upside.

Range-Bound Price Signals Balance, Not Breakout

BTC Range Bound In Shorter Time Frames (Source: TradingView)

Support has formed near $85,000, where buyers stepped in following the November flush. 

While that level has held, Bitcoin has struggled to generate follow-through away from it.

Price remains trapped in a broad consolidation range between roughly $88,000 and $94,000. 

On the one-hour chart, repeated failures near the upper boundary and steady bids near the lower end point to heavy consolidation.

Spot Outflows Weigh On Upside Attempts

BTC On-Chain Flows (Source: Coinglass)

Over the past two weeks, Bitcoin has recorded approximately $2.39 billion in net spot outflows.

Even during recent rebound sessions, capital has continued to exit exchanges, a dynamic that typically limits upside momentum.

This divergence explains why the market feels heavy. 

Buyers are present enough to prevent a breakdown, but sellers continue to cap rallies.

What Needs To Change For The Bull CaseFor Bitcoin to credibly reopen the path toward higher targets, several conditions must be met. 

Price needs to reclaim and hold above $94,000. 

The falling daily trendline must be broken decisively. 

Spot flows must shift from persistent outflows to sustained inflows.

Until those signals appear, upside projections toward $150,000 remain premature.

Read Next:

Bitcoin, Other Cryptocurrencies To Face UK Regulatory Framework By 2027: Report
Photo: jira pliankharom / Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
2025-12-15 16:31 4mo ago
2025-12-15 10:48 4mo ago
Bitcoin May Be Repeating 1929 Great Depression, Top Bloomberg Strategist Warns cryptonews
BTC
Mon, 15/12/2025 - 15:48

Once in a while, Mike McGlone from Bloomberg puts an uncomfortable Bitcoin chart on the table and attaches a date investors would rather forget.

Cover image via U.Today

Disclaimer: The opinions expressed by our writers are their own and do not represent the views of U.Today. The financial and market information provided on U.Today is intended for informational purposes only. U.Today is not liable for any financial losses incurred while trading cryptocurrencies. Conduct your own research by contacting financial experts before making any investment decisions. We believe that all content is accurate as of the date of publication, but certain offers mentioned may no longer be available.

In a recent post, Bloomberg Intelligence’s senior macro strategist Mike McGlone drew a direct parallel between the Bloomberg Galaxy Crypto Index in 2025 and the Dow in 1929, calling the setup "Peak Bitcoin?" and framing the current phase as the early stage of a purge, not a pause — a purge similar to the one that caused the Great Depression almost 100 years ago.

The comparison is not abstract. Bloomberg’s own normalization shows crypto tracking the same arc as U.S. equities did a century ago: a powerful run-up, expanding speculation, then a slow turn lower. 

Source: Mike McGloneMcGlone argues this is exactly when bubble-versus-not-bubble debates explode, usually close to highs, not bottoms. For him, Bitcoin, tightly linked to wide risk markets, fits that script.

HOT Stories

First surge, then purgeHe describes Bitcoin’s post-2024 surge as a beach ball forced underwater until the 2024 reelection removed political pressure. Since then, the price accelerated fast, speculative appetite followed and excess piled up. Now, in McGlone’s words, it is the cleansing phase that appears to be underway. Bitcoin is down only about 5% in 2025 through Dec. 14, which he frames as resilience that may mask larger downside risk rather than confirm safety.

You Might Also Like

The warning widens when gold enters the picture. The Bitcoin-to-gold ratio ended 2022 near 10, ballooned during the crypto rally, then fell about 40% this year to around 21. McGlone sees a path back toward 10 by 2026, a move that historically pressures all risk assets. 

The most jarring projection by McGlone lands last: Bitcoin’s run above $100,000 may have planted the conditions for a long pullback, with even $10,000 cited as a potential destination into 2026, alongside a broader downturn led by high-supply speculative assets that track nothing tangible.

Related articles
2025-12-15 16:31 4mo ago
2025-12-15 10:49 4mo ago
Ondo Finance to Offer Tokenized U.S. Stocks, ETFs on Solana Early Next Year cryptonews
ONDO SOL
The platform will enable 24/7 trading of U.S. stocks and exchange-traded funds with near-instant settlement, building on Ondo's existing $365 million in tokenized assets. Dec 15, 2025, 3:49 p.m.

Real-world asset (RWA) issuer Ondo Finance is set to offer its tokenized stock and exchange-traded fund (ETF) trading platform on the Solana blockchain early next year, the project announced.

The move will bring its growing catalog of tokenized financial products to one of the fastest blockchain networks, expanding access for retail and institutional investors alike. The platform will allow users to trade U.S. stocks and exchange-traded funds 24/7 through blockchain rails, with settlement happening in seconds.

STORY CONTINUES BELOW

Ondo has issued roughly $365 million in tokenized assets, making it the largest operator in the industry, according to data from RWA.xyz. The second-largest participant, Backed Finance with around $162 million in tokenized assets was acquired by Kraken earlier this month.

Ondo’s Solana integration follows its October expansion to the BNB Chain, which opened access to 3.4 million daily users. The broader market for tokenized real-world assets (RWAs) has more than doubled since August, nearing $700 million in total value locked.

The platform's momentum has also benefited from a regulatory tailwind. Last week, the U.S. Securities and Exchange Commission closed a confidential investigation into Ondo without filing charges.

AI Disclaimer: Parts of this article were generated with the assistance from AI tools and reviewed by our editorial team to ensure accuracy and adherence to our standards. For more information, see CoinDesk's full AI Policy.

More For You

Protocol Research: GoPlus Security

Nov 14, 2025

What to know:

As of October 2025, GoPlus has generated $4.7M in total revenue across its product lines. The GoPlus App is the primary revenue driver, contributing $2.5M (approx. 53%), followed by the SafeToken Protocol at $1.7M.GoPlus Intelligence's Token Security API averaged 717 million monthly calls year-to-date in 2025 , with a peak of nearly 1 billion calls in February 2025. Total blockchain-level requests, including transaction simulations, averaged an additional 350 million per month.Since its January 2025 launch , the $GPS token has registered over $5B in total spot volume and $10B in derivatives volume in 2025. Monthly spot volume peaked in March 2025 at over $1.1B , while derivatives volume peaked the same month at over $4B.View Full Report

More For You

Anchorage Digital Buys Securitize’s RIA Platform to Expand Wealth Management Business

14 minutes ago

The bank has bought the Securitize For Advisors unit, bringing the RIA-focused crypto wealth management platform in-house.

What to know:

Anchorage Digital acquired Securitize For Advisors (SFA), a crypto platform for RIAs.The deal consolidates an existing custody relationship, with 99% of SFA assets held at Anchorage.Securitize will refocus on tokenization as Anchorage expands its wealth management offering.Read full story
2025-12-15 16:31 4mo ago
2025-12-15 10:51 4mo ago
WSJ: JPMorgan Rolls Out $100M Tokenized Fund on Ethereum cryptonews
ETH
TL;DR

Launch Impact: JPMorgan has seeded $100M of its own capital into the MONY fund, its first tokenized money market product on Ethereum.
Investor Access: The MONY fund requires a minimum subscription of $1 million, with thresholds of $5 million for individuals and $25 million for institutions.
Industry Shift: Ethereum continues to dominate tokenized finance, already hosting BlackRock’s $2B BUIDL fund. JPMorgan’s entry reinforces the rapid institutional embrace of tokenization.

JPMorgan Chase has taken another decisive step into blockchain finance, unveiling its first tokenized money market fund on the Ethereum network. Seeded with $100 million of its own capital, the initiative signals how one of Wall Street’s largest banks is adapting traditional cash products to meet growing demand for on-chain yield and faster settlement. The launch, reported by the Wall Street Journal, underscores a pivotal moment in the convergence of mainstream banking and decentralized technology.

MONY Fund Details
The new product, dubbed the My OnChain Net Yield Fund (MONY), is managed by JPMorgan Asset Management and supported by the bank’s Kinexys Digital Assets platform. Designed for qualified investors, the fund requires a minimum entry of $1 million, with eligibility thresholds of $5 million for individuals and $25 million for institutions. Subscriptions are processed through JPMorgan’s Morgan Money portal, where investors receive digital tokens representing fund shares directly into their crypto wallets.

Stablecoin Integration
Investors can subscribe or redeem using cash or USDC, Circle’s dollar-linked stablecoin. Like traditional money market funds, MONY invests in short-term debt instruments and accrues income daily. According to John Donohue, head of global liquidity at JPMorgan Asset Management, client interest in tokenization has surged since the passage of the Genius Act, which established a clearer U.S. framework for stablecoins and tokenized dollars.

Industry Context
JPMorgan’s move aligns with a broader industry trend. In July, Goldman Sachs and BNY Mellon announced collaborations on digital tokens tied to money market funds managed by BlackRock and Fidelity. Meanwhile, in Europe, Amundi, the continent’s largest asset manager, launched its own tokenized fund on Ethereum in November, marking its first on-chain transaction earlier that month.

Ethereum’s Role
Ethereum has emerged as the preferred network for tokenized real-world assets and stablecoins. The platform already hosts BlackRock’s BUIDL fund, which manages more than $2 billion, making it the largest example of tokenized money market products to date. JPMorgan’s MONY fund adds another heavyweight to Ethereum’s expanding roster of institutional-grade financial instruments.